CA2110259C - Universal water-based medical and dental cement - Google Patents
Universal water-based medical and dental cement Download PDFInfo
- Publication number
- CA2110259C CA2110259C CA002110259A CA2110259A CA2110259C CA 2110259 C CA2110259 C CA 2110259C CA 002110259 A CA002110259 A CA 002110259A CA 2110259 A CA2110259 A CA 2110259A CA 2110259 C CA2110259 C CA 2110259C
- Authority
- CA
- Canada
- Prior art keywords
- water
- cement
- glass
- cement according
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B28/00—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
- C04B28/28—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing organic polyacids, e.g. polycarboxylate cements, i.e. ionomeric systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
- A61K6/887—Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61K6/889—Polycarboxylate cements; Glass ionomer cements
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
- C04B2111/00474—Uses not provided for elsewhere in C04B2111/00
- C04B2111/00836—Uses not provided for elsewhere in C04B2111/00 for medical or dental applications
Abstract
Dental cement containing water, acid-reactive filler, water-miscible acidic polymer, an ethylenically-unsaturated moiety, photoinitiator, water-soluble reducing agent and water-soluble oxidizing agent. The cement has three curing modes, namely an acid-filler ionic reaction, a photoinitiated crosslinking reaction and a redox-initiated crosslinking reaction. The cement cures well in thick layers, and can be used without a dental curing light or with a light that is weak or defective.
Description
vvc~ ~ziz~3~a ~crius~zioa~c~a _i_ UNIVERBAI. 69'ATER-BABED MET11CT~L AND DENTAL ~E~IE~1'T
Tech~,'~ .~ e~.dl This invention relates to water-based medical and dental cements.
roc Resin-based composite and restorative materials generally have very high cohesive strength, and accordingly are widely used in dentistry. However, in recent years there has been a resurgence in water-based cements. These water-based cements may contain resinous components, but are distinguished by containing substantial amounts of water. Examples include mortal oxide cements such as those deacxibed in U.s. Pat. No. 3,655,605 and fluoroaluminosilicate glass cements (also known as "glass ionomer cements") such as those described in Example 6 of the '605 patent and in U.S. Pat. Idol. 3,814,717, 4,043,327, 4,143,018, and 4,209,434. These water-based cements havetalso found utility in medical applications such as the fabrication of orthopedic bandages, as described in U. S. Pat. Nos.°
4,043,327 and x,243,567.
Typically, these cements are cured or hardened by combining a polyfunctional acid, water and an acid-reactive metal oxide or glass filler.
Hardening occurs due to the reaction between the acidic groups of the polyfunctional acid and cations leached.
from the filler: lkoxe' recently, light-curable water-based cements have appeared. Examples are shown in U,S. Pat. No. 4,872,936,,European Pat. Application Nos. 0 323 120 and 0 329 2S8 and Australian Published Pat. Specification P1~. 4671T/89. These light-curable cements include one or more ethylenically-unsaturated components and a suitable photoinitiator. Hardening WOl2/21314 ~ ~ nCflUS~2/041G4 _2_ takes place independently from the acid-filler reaction mentioned above via crosslinking of the ethylenically-unsaturated component upon exposure of the photainitiator to light or other activating energy.
A light-curable and apparently anhydrous cement is shown in European Pat. Application No.
0 391 619. It contains a number of ingredients, including benzoyl peroxide.
Although light-curable cements have many l0 advantages, they do require use of a light. If the light is defective (for example, due to breakage or discoloration of the filters typically installed in the light path or through deterioration of the curing lamp , then the composition may undergo incomplete light-curing polymerization. Also, owing to the need to insure adequate penetration of the light energy into tine cement, thick restorations typically must be built up in separately cured thin layers. In some dentalw applications it may be impractical to use a curing light. For example, when luting a metallic crown to a prepared tooth stump, light typically will not penetrate underneath the crown. Likewise,pfor endodontic applications, light may not penetrate the full depth of the endodontic preparation. On the other' hand a cement that cures only by dark reactions takes a long time to cure. During this time the cement may be prone to moisture contaminat3:on.
AGCOrdingly, presently available cements have not had universal applicability. This has led to the appearance of many special-purpose products in the marketplace, with attendant need for the practitioner to maintain separate inventories of each cement, to undergo training in the use of more than ane cement, and to avoid improper use through inadvertent selection 3 5 of the wrong' cement .
Suamnary of the Invention The present invention provides a cement having three curing modes. The cement cures through a first mechanism, via an acid-filler ionic reaction. The cement cures through a second mechanism, via photoinitiated free radical crosslinking of an ethylenically-unsaturated component. Finally, the cement cures through a third mechanism, via redox-initiated free radical crosslinking of the ethylenically-unsaturated component. The cement can be used in a wide variety of applications, and will provide good results even if a dental curing light is not used or is improperly used. The cement is water-based, and thus can be used under moist conditions such as are typically present in the mouth.
The invention provides, in one aspect, a water-containing, sonically-hardenable, photocurable, ethylenically-unsaturated dental cement, comprising a) finely-divided acid-reactive filler, b) water-miscible acidic polymer, c) photoinitiator, d) water-soluble reducing agent, and e) water-soluble oxidizing agent.
Preferably, the reducing agent and the oxidizing agent are capable of initiating gelation of a 10:10:1 (weight basis) water:acrylamide:methylene bis-acrylamide mixture.
In a further aspect, the invention provides preferred cements in which the reducing agent or the 3a oxidizing agent are contained in microcapsules. The microcapsules improve shelf life and facilitate packaging.
The invention further provides a dental cement powder, comprising finely-divided acid-reactive filler, water-soluble reducing agent and water-soluble oxidizing agent, at least one of the agents being microencapsulated.
The invention also provides a dental cement liquid, comprising water-miscible acidic polymer, water-soluble reducing agent and water-soluble oxidizing agent, at least one of the agents being microencapsulated.
Detailed Description Generally, the cements of the invention are formulated in two parts, although formulations employing three or more parts can be made up if WU 9Z/Z1314 ~GT/U592/04164 2~.102~~3 -~~
desired. In a two part formulation, the first part typically is a powder portion'containing the acid-reactive (filler. The second part typically is a liquid portion containing the acidic polymer, water and one (but usually not both) of the water-soluble . reducing agent and water-soluble oxidizing agent. If .
the reducing agent is present in the liquid portion, then the oxidizing agent is typically present in the powder portion, and vice-versa. The reducing agent and l0 oxidizing agent can be combined in the powder portion or in the l3.quid portion through the use of a microencapsulation technique described in more detail below.
The invention is not limited to powder: liquid formulations. For example, one part anhydrous formulations containing filler, polymer, photoinitiator, reducing agent and oxidizing agent c.an be prepared. These can be sold in dry form and w prepared for use by adding water. Also, two part paste:paste formulations can be prepared by adding to the acid-reactive filler a suitable polymerizable liquid that does not react with that filler-(e. g., 2-hydroxyethyl methaarylate, or "HEMA"j, yielding a first paste. The acidic polymer described above is combined with a suitable filler that does not react with the acidic polymer (e. g., ground quartz), yielding a second paste: The two pastes are prepared for use by stirring them together. Other useful configurations will be familiar to those skilled in the art. However, for simplicity, the remainder of this patent specification wil'1 refe=~ to' powder: liquid formulations unless specifically noted otherwise.
The cements of the invention contain water.
The water can be present in the product as sold, or added by the dentist just prior to use. The water can be distilled, deionized or plain tap water. Generally, deionized water is preferred. The amount of water wm ~zizmaa ~crsus~zioa~ba -5- ~1~.0~~~
should be sufficient to provide adequate handling and mixing properties and to perrait the transport of ions in the filler-acid reaction. Preferably, water represents at least about 1%, more preferably about 3%
to about 25%, and most preferably about 5% to about 20%
of the total weight of ingredients used to Form the cement.
The cements of the invention are sonically hardenable. ~y this is meant that they contain ingredients that, when combined, can react via an ionic reaction to produce a hardened mass. The ionic reaction occurs between acrd groups on the polymer and acid-reactive groups on the filler.
The cements of the invention are also ethylenically-unsaturated. xn other words, they contain at least one ethylenically-unsaturated moiety.
The ethylenically-unsaturated moiety can be present as a separate ingredient (for example, as an acrylate-°or methacrylate-functional monomer) or it can, if desired, be present as a group on another ingredient such as the acidic polymer. A wide variety of ethylenically-unsaturated moieties can be used. A useful list of suitable materials is shown at page 9, line 13 through page 13, last line of Australian Published Pat. ' Specification No. 46?1?/89. C~f the many materials mentioned, water-miscible or water-soluble acrylates and methacrylates such as 2-hydroxyethyl methacrylate, hydroxymethyl methacrylate, 2-hydroxypropyl methacrylate, tetrahydrofurfuryl methacrylate, glycerol mono- or di-methacrylate, trimethylol propane trimethacrylate, ethy~.ene iglycol ~dimethacrylate, polyethylene glycol dimethacrylate, urethane methacrylates, acrylamide, methacrylamide, methylene bis-acrylamide or methacrylamide, and diacetone acrylamide and m~thacrylamide are preferred. Mixtures of ethylenically-unsaturated moieties can be used if desired. Preferably, the ethylenically-unsaturated _g_ moieties are present as groups on the acidic polymer, as described in more detail below.
The cements of the invention also contain an acid-reactive filler. The filler should be sufficiently finely-divided sa that it can be conveniently mixed with the other ingredients and used in the mouth. Preferred average particle diameters for the filler are about 0.2 to about 15 micrometers, more preferably about 1 to la micrometers, as measured using, for example, a sedimentation analyzer.
Suitable acid-reactive fillers include metal oxides, metal salts and glasses. Preferred metal oxides include barium oxide, calcium oxide, magnesium oxide and zinc oxide. Preferred metal salts include salts of multivalent rations, for example aluminum acetate, aluminum chloride, calcium chloride, magnesium chloride, zinc chloride, aluminum nitrate, barium nitrate, calcium nitrate, magnesium »itrate, strontium nitrate and calcium fluoroborate. Preferred glasses include borate glasses, phosphate glasses and fluoroaluminosilicate glasses. Fluoroaluminosilicate glasses are particularly preferred. Suitable fillers are also available from a variety of commercial sources familiar to those skilled in the art. For example, ' suitable fillers can be obtained from a number ~f commercially available glass ionomer cements, such as "GC Fuji LC" cement and "Kerr SCR" ionomer cement.
Mixtures of fillers can be used if desired.
If desired, the filler can be subjected to a surface treatment. Suitable surface treatments include acid washing,'trehtmerit'with phosphates, treatment with chelating agents such as tartaric acid, treatment with a silane as described in Australian Published Pat. No.
46717/89, and treatment with an acidic si~,anol solution.
The amount of filler should be sufficient to provide a cement having desirable mixing and handling _~_ 2~.10~5J
properties before cure, arid good cement performance after cure. Preferably, the~filler represents less than about 90%, more preferably about 25% to about 85%, and most preferably about 50% to about ?5% by weight of the total weight (including water) of the onset cement components.
The acidic polymer need not be entirely water soluble, but it should be at least sufficiently water-miscible so that it does not undergo substantial sedimentation when combined with the liquid ingredients of the cement. Suitable acidic polymers include those listed at column 2, line 62 through column 3, line 6 of U.S. Patent No. 4,209,434. Preferred acidic polymers include homopolymers and copolymers of alkenoic acids such as acrylic acid, itaconie acid and maleic acid.
Suitable polymers are also available from a wide variety of commercial sources, and many are found in currently-available glass ianamer cements. As wilh be appreciated by those skilled in the art, the polymer should have a molecular weight sufficient to provide good storage, handling and mixing properties. A
preferred molecular weight is about 5000 to about 100,000 weight average molecular weight (Pt,~,), evaluated against a pAlystyrene standard using gel permeation' chromatography: Preferably, the acidic polymer contains one or more ethylenically-unsaturated groups.
Suitable ethylenically-unsaturated acidic polymers are described in U.S. Pat: No: 4,8?2,936 and in European Pat. Application No. 4 323 120. Preferably, the numbers of acid groups and ethylenically-unsaturated .
,, ;
groups~are adjusted to provide an appropriate balance of properties in the cement, both during the setting reaction and after the cement has hardened. Acidic polymers in which about'l0 to about 30% of the acidic groups have been replaced with ethylenically-unsaturated groups are preferred.
WO 92/2I314 ~ PCf'/US92/U4164 ~~~~4~~~
... g ..
The amount of acidic polymer in the cement should also be sufficient to~provide a desired balance of physical properties. A preferred acidic polymer ' amount is at least about 5%, more preferably about 10 to about 50%, and most preferably about 10 to about 30%
of the total we~:ght (including water) of the upset cement components.
The photoinitiator should be capable of promoting free radical crossiinking of the ethylenically-unsaturated component on exposure to light of a suitable wavelength and intensity. It also preferably is ssufficiently shelf--stable and free of undesirable coloratian to permit its storage and use under typical dental conditions. Visible light photoinitiators are preferred. The photoinitiator preferably is water-soluble or water-miscible.
Photoinitiators bearing polar groups usually have a sufficient degree of water-solubility or water-miscibility. The photoinitiator frequently can be used alone but typically it is used in combination with a suitable donor compound or a suitable accelerator (for example, amines, peroxides, phosphorus compounds, ketones and alpha-diketone compounds).
Preferred visible light-induced initiators include camphorquinone (which typically is combined with a suitable hydrogen donor such~as an amine), diaryliodonium simply or metal complex salts, chromophore-substituted halomethyl-s-triazines and halomethyl oxadiazoles: Particularly preferred visible light-induced photoinitiators include combinations of.
an alpha-diketone;' e.g~,~' camphorquinone, and a diaryliodonium salt, eg., diphenyliodonium chloride, bromide.' iodide or hexaf luorophosphate, with or without additional hydrogen donors (such as sodium benzene sulfinate, amines and amine alcohols).
Preferred ultraviolet light~induced polymerization initiators include ketones such as benzyl and benzoin, WO 92/21314 2 ~ ~ 4 ~ ~ g PCT/US9z/041G4 _g..
and acyloins and acyloin ethers. Preferred commercially available ultraviolet light-induced polymerization initiators include 2,2-dimethoxy-2-phenylacetophenone ("IRGACURE 652") and benzoin methyl ether (2-methoxy-2-phenylacetophenon~), both from Ciba-Geigy Corp.
The photoinitiator should be present in an amount sufficient to provide the desired rate of photopolymerization. This amount will be dependent in l0 part on the light source, the thickness of the cement layer to be exposed to radiant energy, and the extinction coefficient of the photoinitiator.
Typically, the photoinitiator components will be present at a total weight of about 0.01 to about 5%, more preferably from about 0.1 to about 5%, based on the total weight (including water) of the upset cement components. The photoinitiator can be included in either the paste or liquid parts of the cement.
The water-soluble reducing agent and water-soluble oxidizing agent are most conveniently discussed together. They should react with or otherwise cooperate with one another to produce free=radicals capable of initiating polymerization of the ethylenically-unsaturated moiety. The reducing agent ' and oxidizing agent preferably are sufficiently.
shelf-stable and free of undesirable colonization to permit their stonage and use under typical dental conditions. They should be sufficiently water-soluble to permit ready dissolution in (and discourage separation from) the other components of the cement. .
The reducing agent and oxidizing agent should also b'e sufFiciently soluble and present in an amount sufficient to permit an adequate free-radical reaction rate: This can be evaluated by combining all of the ingredients of the cement except for the ffiller under safelight conditions; and observing whether or not a hardened mass is obtained.
WU h2/21314 P~'1'1US92104164 -m_ The reducing agent arid oxidizing agent preferably are sufficiently vaater-soluble and have cuff icient reduction and oxidation potentials to initiate gelation of an aqueous crosslinkable acrylamide solution. This can be evaluated by adding 2 ws:ight % each of the reducing agent and the oxidizing agent to an aqueous acrylamide:methylene bis-acrylamide solution (described below in Table Ia) and observing whether or not gelation occurs within 30 minutas.
Useful reducing agent/oxidizing agent pairs are shown in ~~~tedox polymerization~~, G. s. Misra and U. D. 1~.
~~~pai, ~~ ~~~. ~c~r . ~, ~~-131 (~~~2) .
Preferred reducing agents include ascorbic acid, cobalt (II) chlorid~, ferrous chloride, ferrous sulfate, hydrazine, hydroxylamine (depending upon the choice of oxidizing agent) oxalic acid, thiourea, and salts of a dithionite or sulfite anion. Preferred oxidizing agents include cobalt (III) chloride, tart-butyl hydroperoxide, ferric chloride, hydroxylamine (depending upon the choice of reducing agent), perboric acid and its salts, and salts of a permanganate or persulfate anion. Hydrogen peroxide can also be used, although it has been found to interfere with the photoinitiator in some instances.
The amount of reducing agent and oxidizing agent should be sufficient to provide the desired degree of polymerization of the ethylenically-unsaturated component. The preferred amount for each of the reducing agent and oxidizing agent is about 0.01 to about 10%, more preferably about 0.02 to about 5%,.
based on the total weight~(including water) of the ' upset cement components.
As mentioned above, the reducing agent or the oxidizing agent can be microencapsulated. This will generally enhance shelf stability and permit packaging both the reducing agent and oxidizing agent together.
For example, through appropriate selection of the WC? ~l2/z1314 PCf/U592/04y64 encapsulant, both the oxidizing agent and reducing agent can be combined with the filler and kept in a storage-stable state. Likewise, through appropriate selection of a water-insoluble encapsulant, the reducing agent and oxidizing agent can be combined with water and the acidic polymer and maintained in a storage-stable state.
Hither water-soluble or water-insoluble encapsulants can be employed. However, water-insoluble encapsulants are preferred, as they generally provide better long term storage stability under moist or humid conditions. Although the use of a water-insoluble encapsulant may initially seem inappropriate in a water-based cement, it has been found that vigorous I5 mechanical mixing generally will be sufficient to break apart the capsule walls and permit adequate release of the encapsulated reducing agent or oxidizing agent and subsequent cure of the cement.
Preferably the encapsulant is a medically acceptable polymer and a good film former. Also, the glass transition temperature (Tg) of the encapsulant preferably is above room temperature.
A wide variety of encapsulants can be used, with cellulosic materials as cellulose acetate, ' 25 cellulose acetate butyrate, ethyl cellulose, , hydroxymethyl cellulose and hydroxyethyl cellulose being preferred: Other encapsulants include polystyrene, copolymers of polystyrene with other vinylic monomers, polymethylmethacrylate, copolymers of methylmethacrylate with other ethylenically-unsaturated monomer's, and other materials that will be familiar~to those skilled in the art of encapsulation.
The capsules themselves need not be perfectly spherical nor uniformly shaped. It~is merely sufficient that they entrain or entrap the encapsulated reducing agent or oxidizing agent in a manner sufficient to permit storage of the encapsulated CJ ~ -12 material in a cement component without leading to undesirable premature polymerization.
To encapsulate the reducing agent or oxidizing agent in a water-insoluble encapsulant, it is preferred to dissolve the encapsulant in a suitable water-immiscible solvent such as methyl acetate, ethyl acetate or methylene chloride. Meanwhile, the reducing agent or oxidizing agent is dissolved in water. The water solution can then be added to the solution of l0 encapsulant arid water-fmmiscible solvent. stirring or other high speed shear techniques preferably are used to promote uniform microcapsule formation. The capsule shells are formed around the aqueous solution droplets either by evaporation of the water-immiscible solvent or by the addition of a secand water-immiscible solvent (e. g., n-hexane) that will precipitate the encapsulant.
The capsules can then be removed by cooling and filtration. "
To encapsulate the reducing agent or oxidizing agent in a water-soluble encapsulant, the dry reducing agent or oxidizing agent is preferably suspended in a stirred solution of the encapsulant in a water-immiscible organic solvent. Vigorous stirring will promote uniform encapsulation of the reducing agent or oxidizing agent: The capsules can be formed by evaporation or by precipitation and then removed using the techniques described above.
If desired, the cements of the invention can contain adjuvants such as pigments, nonvitreous fillers, inhibitors, accelerators, viscosity modifiers, surfactants; amd otheringredients that will be _ apparent to those skilled in the art.
The cements of the invention can be mixed and clinically applied using conventional techniques.
However; the cements will have particular utility in clinical applications where cure of a conventional light-curable cement may be difficult to achieve. Such WO 92/21314 n P~'1'/US92104164 '-13-applications include deep restorations, large crown build-ups, endodontic restorations, luting of metallic crowns or other light-impermeable prosthetic devices to teeth, and other restorative applications in inaccessible areas of the mouth. The three-way cure mechanism facilitates thorough, uniform cure and retention of goad clinical properties. The cements of the invention thus show good promise as a universal restorative.
l0 The cements of the invention are further described in the following illustrative examples, which should not be construed as limiting the scope of the invention. Unless otherwise indicated, all parts and percentages are on a weight basis.
EZliMPLE
cements preparsd oeing'V'arioua Curiag Modes A test solution was prepared by combining the ingredients set out below in Table Ia:
Table =a =ngrodiants pants Acrylamide 30 Methylene bis-acrylamide 3 2 5 Water 3 0 ~
In a series of four runs a 2g portion of the test solution was placed in a glass test tube. For each 30 run, 2% of the, ingredients set out below in Table Iby were added to a separate test tube with shaking:
wo ~2iz~~m ~criu~h2ia4~ba ~1~
Table ~b ' ~,ur~ ~o. ~ lead~d x~agrgd3.e~ats 1 Potassium Persulgate As~:orbic Acid 2 Potassium Peraulfate Thiourea 3 Potassium PersulEate Oxalic Acid 4 Ammonium .Persulfate Ascorbic Acid The contents of the two test tubes were combined with shaking. Far each run, gelation and an exotherm were observed within seven minutes.
The ingredients set out below in Table IIa were mixed, melted in an arc furnace at about 1350-1450°C, poured from the furnace in a thin stream and quenched using chilled rollers to provide an amorphous single-phase fluoroaluminosilicate glassy Table IIa Ingredient gart~
Si0 3?
AlF 23 SxO 20 A1~0~ 10 Na A1F 6 ., ,, p Q 4 The glass was ball-ma.Iled to provide a pulverized frit with a surface area of 2.6 m2/g measured using the Brunauer, Emmet and Teller (BET) method. The pulverized glass was labeled "Control Glass". 20 Parts swo 9xizma ~criu~~z~n4ma _,.5- 2110~~~
of the Control Glass were mined with a solution of 0.1 parts ascorbic acid (a water=soluble reducing agent) in 39.5 parts methanol, and stirred for 10 minutes using a magnetic stirrer. The wet glass was poured into a dish to a depth less than 1 cm, and then dried in a 45°C
oven for 16 hours. The dried glass was sieved through 3 74 ~Cm mesh screen, and labeled "Glass A".
The ingredients get out below in Table IIb were mixed using a paint shaker to provide two cement-forming liquids labeled "Control Liquid" and "Liquid A". Each liquid contained ethylenically-unsaturated components (as groups on the copolymer and as a separate ingredient), and carboxylic acid (as groups on the copolymer). Liquid A also contained potassium persulfate (a water-soluble oxidizing agent):
Table IIIa .,~ _ ~ T, Cement-forming liquid~r, parts ~'~'~' Ingredient ""'-Control Liquid Liquid i~
Copolymers 50 50 Water2 30 30 HEr~A~ 2 a 2 0 C H ) I'~PF - 0 . 7 0 . 7 CP~4 ' 0.25 0.25 BHT~ 0.1 0.1 K S O -'-- 0.05 Ethylenically-unsaturated acidic copolymer prepared like the precipitated dry polymer of 3C) EXAMPLE 1l of European Published Pat. Application:
No. 0 323 120.
Distilled water.
2-Hydroxyethyl methacrylate.
Camphorquinone.
Tech~,'~ .~ e~.dl This invention relates to water-based medical and dental cements.
roc Resin-based composite and restorative materials generally have very high cohesive strength, and accordingly are widely used in dentistry. However, in recent years there has been a resurgence in water-based cements. These water-based cements may contain resinous components, but are distinguished by containing substantial amounts of water. Examples include mortal oxide cements such as those deacxibed in U.s. Pat. No. 3,655,605 and fluoroaluminosilicate glass cements (also known as "glass ionomer cements") such as those described in Example 6 of the '605 patent and in U.S. Pat. Idol. 3,814,717, 4,043,327, 4,143,018, and 4,209,434. These water-based cements havetalso found utility in medical applications such as the fabrication of orthopedic bandages, as described in U. S. Pat. Nos.°
4,043,327 and x,243,567.
Typically, these cements are cured or hardened by combining a polyfunctional acid, water and an acid-reactive metal oxide or glass filler.
Hardening occurs due to the reaction between the acidic groups of the polyfunctional acid and cations leached.
from the filler: lkoxe' recently, light-curable water-based cements have appeared. Examples are shown in U,S. Pat. No. 4,872,936,,European Pat. Application Nos. 0 323 120 and 0 329 2S8 and Australian Published Pat. Specification P1~. 4671T/89. These light-curable cements include one or more ethylenically-unsaturated components and a suitable photoinitiator. Hardening WOl2/21314 ~ ~ nCflUS~2/041G4 _2_ takes place independently from the acid-filler reaction mentioned above via crosslinking of the ethylenically-unsaturated component upon exposure of the photainitiator to light or other activating energy.
A light-curable and apparently anhydrous cement is shown in European Pat. Application No.
0 391 619. It contains a number of ingredients, including benzoyl peroxide.
Although light-curable cements have many l0 advantages, they do require use of a light. If the light is defective (for example, due to breakage or discoloration of the filters typically installed in the light path or through deterioration of the curing lamp , then the composition may undergo incomplete light-curing polymerization. Also, owing to the need to insure adequate penetration of the light energy into tine cement, thick restorations typically must be built up in separately cured thin layers. In some dentalw applications it may be impractical to use a curing light. For example, when luting a metallic crown to a prepared tooth stump, light typically will not penetrate underneath the crown. Likewise,pfor endodontic applications, light may not penetrate the full depth of the endodontic preparation. On the other' hand a cement that cures only by dark reactions takes a long time to cure. During this time the cement may be prone to moisture contaminat3:on.
AGCOrdingly, presently available cements have not had universal applicability. This has led to the appearance of many special-purpose products in the marketplace, with attendant need for the practitioner to maintain separate inventories of each cement, to undergo training in the use of more than ane cement, and to avoid improper use through inadvertent selection 3 5 of the wrong' cement .
Suamnary of the Invention The present invention provides a cement having three curing modes. The cement cures through a first mechanism, via an acid-filler ionic reaction. The cement cures through a second mechanism, via photoinitiated free radical crosslinking of an ethylenically-unsaturated component. Finally, the cement cures through a third mechanism, via redox-initiated free radical crosslinking of the ethylenically-unsaturated component. The cement can be used in a wide variety of applications, and will provide good results even if a dental curing light is not used or is improperly used. The cement is water-based, and thus can be used under moist conditions such as are typically present in the mouth.
The invention provides, in one aspect, a water-containing, sonically-hardenable, photocurable, ethylenically-unsaturated dental cement, comprising a) finely-divided acid-reactive filler, b) water-miscible acidic polymer, c) photoinitiator, d) water-soluble reducing agent, and e) water-soluble oxidizing agent.
Preferably, the reducing agent and the oxidizing agent are capable of initiating gelation of a 10:10:1 (weight basis) water:acrylamide:methylene bis-acrylamide mixture.
In a further aspect, the invention provides preferred cements in which the reducing agent or the 3a oxidizing agent are contained in microcapsules. The microcapsules improve shelf life and facilitate packaging.
The invention further provides a dental cement powder, comprising finely-divided acid-reactive filler, water-soluble reducing agent and water-soluble oxidizing agent, at least one of the agents being microencapsulated.
The invention also provides a dental cement liquid, comprising water-miscible acidic polymer, water-soluble reducing agent and water-soluble oxidizing agent, at least one of the agents being microencapsulated.
Detailed Description Generally, the cements of the invention are formulated in two parts, although formulations employing three or more parts can be made up if WU 9Z/Z1314 ~GT/U592/04164 2~.102~~3 -~~
desired. In a two part formulation, the first part typically is a powder portion'containing the acid-reactive (filler. The second part typically is a liquid portion containing the acidic polymer, water and one (but usually not both) of the water-soluble . reducing agent and water-soluble oxidizing agent. If .
the reducing agent is present in the liquid portion, then the oxidizing agent is typically present in the powder portion, and vice-versa. The reducing agent and l0 oxidizing agent can be combined in the powder portion or in the l3.quid portion through the use of a microencapsulation technique described in more detail below.
The invention is not limited to powder: liquid formulations. For example, one part anhydrous formulations containing filler, polymer, photoinitiator, reducing agent and oxidizing agent c.an be prepared. These can be sold in dry form and w prepared for use by adding water. Also, two part paste:paste formulations can be prepared by adding to the acid-reactive filler a suitable polymerizable liquid that does not react with that filler-(e. g., 2-hydroxyethyl methaarylate, or "HEMA"j, yielding a first paste. The acidic polymer described above is combined with a suitable filler that does not react with the acidic polymer (e. g., ground quartz), yielding a second paste: The two pastes are prepared for use by stirring them together. Other useful configurations will be familiar to those skilled in the art. However, for simplicity, the remainder of this patent specification wil'1 refe=~ to' powder: liquid formulations unless specifically noted otherwise.
The cements of the invention contain water.
The water can be present in the product as sold, or added by the dentist just prior to use. The water can be distilled, deionized or plain tap water. Generally, deionized water is preferred. The amount of water wm ~zizmaa ~crsus~zioa~ba -5- ~1~.0~~~
should be sufficient to provide adequate handling and mixing properties and to perrait the transport of ions in the filler-acid reaction. Preferably, water represents at least about 1%, more preferably about 3%
to about 25%, and most preferably about 5% to about 20%
of the total weight of ingredients used to Form the cement.
The cements of the invention are sonically hardenable. ~y this is meant that they contain ingredients that, when combined, can react via an ionic reaction to produce a hardened mass. The ionic reaction occurs between acrd groups on the polymer and acid-reactive groups on the filler.
The cements of the invention are also ethylenically-unsaturated. xn other words, they contain at least one ethylenically-unsaturated moiety.
The ethylenically-unsaturated moiety can be present as a separate ingredient (for example, as an acrylate-°or methacrylate-functional monomer) or it can, if desired, be present as a group on another ingredient such as the acidic polymer. A wide variety of ethylenically-unsaturated moieties can be used. A useful list of suitable materials is shown at page 9, line 13 through page 13, last line of Australian Published Pat. ' Specification No. 46?1?/89. C~f the many materials mentioned, water-miscible or water-soluble acrylates and methacrylates such as 2-hydroxyethyl methacrylate, hydroxymethyl methacrylate, 2-hydroxypropyl methacrylate, tetrahydrofurfuryl methacrylate, glycerol mono- or di-methacrylate, trimethylol propane trimethacrylate, ethy~.ene iglycol ~dimethacrylate, polyethylene glycol dimethacrylate, urethane methacrylates, acrylamide, methacrylamide, methylene bis-acrylamide or methacrylamide, and diacetone acrylamide and m~thacrylamide are preferred. Mixtures of ethylenically-unsaturated moieties can be used if desired. Preferably, the ethylenically-unsaturated _g_ moieties are present as groups on the acidic polymer, as described in more detail below.
The cements of the invention also contain an acid-reactive filler. The filler should be sufficiently finely-divided sa that it can be conveniently mixed with the other ingredients and used in the mouth. Preferred average particle diameters for the filler are about 0.2 to about 15 micrometers, more preferably about 1 to la micrometers, as measured using, for example, a sedimentation analyzer.
Suitable acid-reactive fillers include metal oxides, metal salts and glasses. Preferred metal oxides include barium oxide, calcium oxide, magnesium oxide and zinc oxide. Preferred metal salts include salts of multivalent rations, for example aluminum acetate, aluminum chloride, calcium chloride, magnesium chloride, zinc chloride, aluminum nitrate, barium nitrate, calcium nitrate, magnesium »itrate, strontium nitrate and calcium fluoroborate. Preferred glasses include borate glasses, phosphate glasses and fluoroaluminosilicate glasses. Fluoroaluminosilicate glasses are particularly preferred. Suitable fillers are also available from a variety of commercial sources familiar to those skilled in the art. For example, ' suitable fillers can be obtained from a number ~f commercially available glass ionomer cements, such as "GC Fuji LC" cement and "Kerr SCR" ionomer cement.
Mixtures of fillers can be used if desired.
If desired, the filler can be subjected to a surface treatment. Suitable surface treatments include acid washing,'trehtmerit'with phosphates, treatment with chelating agents such as tartaric acid, treatment with a silane as described in Australian Published Pat. No.
46717/89, and treatment with an acidic si~,anol solution.
The amount of filler should be sufficient to provide a cement having desirable mixing and handling _~_ 2~.10~5J
properties before cure, arid good cement performance after cure. Preferably, the~filler represents less than about 90%, more preferably about 25% to about 85%, and most preferably about 50% to about ?5% by weight of the total weight (including water) of the onset cement components.
The acidic polymer need not be entirely water soluble, but it should be at least sufficiently water-miscible so that it does not undergo substantial sedimentation when combined with the liquid ingredients of the cement. Suitable acidic polymers include those listed at column 2, line 62 through column 3, line 6 of U.S. Patent No. 4,209,434. Preferred acidic polymers include homopolymers and copolymers of alkenoic acids such as acrylic acid, itaconie acid and maleic acid.
Suitable polymers are also available from a wide variety of commercial sources, and many are found in currently-available glass ianamer cements. As wilh be appreciated by those skilled in the art, the polymer should have a molecular weight sufficient to provide good storage, handling and mixing properties. A
preferred molecular weight is about 5000 to about 100,000 weight average molecular weight (Pt,~,), evaluated against a pAlystyrene standard using gel permeation' chromatography: Preferably, the acidic polymer contains one or more ethylenically-unsaturated groups.
Suitable ethylenically-unsaturated acidic polymers are described in U.S. Pat: No: 4,8?2,936 and in European Pat. Application No. 4 323 120. Preferably, the numbers of acid groups and ethylenically-unsaturated .
,, ;
groups~are adjusted to provide an appropriate balance of properties in the cement, both during the setting reaction and after the cement has hardened. Acidic polymers in which about'l0 to about 30% of the acidic groups have been replaced with ethylenically-unsaturated groups are preferred.
WO 92/2I314 ~ PCf'/US92/U4164 ~~~~4~~~
... g ..
The amount of acidic polymer in the cement should also be sufficient to~provide a desired balance of physical properties. A preferred acidic polymer ' amount is at least about 5%, more preferably about 10 to about 50%, and most preferably about 10 to about 30%
of the total we~:ght (including water) of the upset cement components.
The photoinitiator should be capable of promoting free radical crossiinking of the ethylenically-unsaturated component on exposure to light of a suitable wavelength and intensity. It also preferably is ssufficiently shelf--stable and free of undesirable coloratian to permit its storage and use under typical dental conditions. Visible light photoinitiators are preferred. The photoinitiator preferably is water-soluble or water-miscible.
Photoinitiators bearing polar groups usually have a sufficient degree of water-solubility or water-miscibility. The photoinitiator frequently can be used alone but typically it is used in combination with a suitable donor compound or a suitable accelerator (for example, amines, peroxides, phosphorus compounds, ketones and alpha-diketone compounds).
Preferred visible light-induced initiators include camphorquinone (which typically is combined with a suitable hydrogen donor such~as an amine), diaryliodonium simply or metal complex salts, chromophore-substituted halomethyl-s-triazines and halomethyl oxadiazoles: Particularly preferred visible light-induced photoinitiators include combinations of.
an alpha-diketone;' e.g~,~' camphorquinone, and a diaryliodonium salt, eg., diphenyliodonium chloride, bromide.' iodide or hexaf luorophosphate, with or without additional hydrogen donors (such as sodium benzene sulfinate, amines and amine alcohols).
Preferred ultraviolet light~induced polymerization initiators include ketones such as benzyl and benzoin, WO 92/21314 2 ~ ~ 4 ~ ~ g PCT/US9z/041G4 _g..
and acyloins and acyloin ethers. Preferred commercially available ultraviolet light-induced polymerization initiators include 2,2-dimethoxy-2-phenylacetophenone ("IRGACURE 652") and benzoin methyl ether (2-methoxy-2-phenylacetophenon~), both from Ciba-Geigy Corp.
The photoinitiator should be present in an amount sufficient to provide the desired rate of photopolymerization. This amount will be dependent in l0 part on the light source, the thickness of the cement layer to be exposed to radiant energy, and the extinction coefficient of the photoinitiator.
Typically, the photoinitiator components will be present at a total weight of about 0.01 to about 5%, more preferably from about 0.1 to about 5%, based on the total weight (including water) of the upset cement components. The photoinitiator can be included in either the paste or liquid parts of the cement.
The water-soluble reducing agent and water-soluble oxidizing agent are most conveniently discussed together. They should react with or otherwise cooperate with one another to produce free=radicals capable of initiating polymerization of the ethylenically-unsaturated moiety. The reducing agent ' and oxidizing agent preferably are sufficiently.
shelf-stable and free of undesirable colonization to permit their stonage and use under typical dental conditions. They should be sufficiently water-soluble to permit ready dissolution in (and discourage separation from) the other components of the cement. .
The reducing agent and oxidizing agent should also b'e sufFiciently soluble and present in an amount sufficient to permit an adequate free-radical reaction rate: This can be evaluated by combining all of the ingredients of the cement except for the ffiller under safelight conditions; and observing whether or not a hardened mass is obtained.
WU h2/21314 P~'1'1US92104164 -m_ The reducing agent arid oxidizing agent preferably are sufficiently vaater-soluble and have cuff icient reduction and oxidation potentials to initiate gelation of an aqueous crosslinkable acrylamide solution. This can be evaluated by adding 2 ws:ight % each of the reducing agent and the oxidizing agent to an aqueous acrylamide:methylene bis-acrylamide solution (described below in Table Ia) and observing whether or not gelation occurs within 30 minutas.
Useful reducing agent/oxidizing agent pairs are shown in ~~~tedox polymerization~~, G. s. Misra and U. D. 1~.
~~~pai, ~~ ~~~. ~c~r . ~, ~~-131 (~~~2) .
Preferred reducing agents include ascorbic acid, cobalt (II) chlorid~, ferrous chloride, ferrous sulfate, hydrazine, hydroxylamine (depending upon the choice of oxidizing agent) oxalic acid, thiourea, and salts of a dithionite or sulfite anion. Preferred oxidizing agents include cobalt (III) chloride, tart-butyl hydroperoxide, ferric chloride, hydroxylamine (depending upon the choice of reducing agent), perboric acid and its salts, and salts of a permanganate or persulfate anion. Hydrogen peroxide can also be used, although it has been found to interfere with the photoinitiator in some instances.
The amount of reducing agent and oxidizing agent should be sufficient to provide the desired degree of polymerization of the ethylenically-unsaturated component. The preferred amount for each of the reducing agent and oxidizing agent is about 0.01 to about 10%, more preferably about 0.02 to about 5%,.
based on the total weight~(including water) of the ' upset cement components.
As mentioned above, the reducing agent or the oxidizing agent can be microencapsulated. This will generally enhance shelf stability and permit packaging both the reducing agent and oxidizing agent together.
For example, through appropriate selection of the WC? ~l2/z1314 PCf/U592/04y64 encapsulant, both the oxidizing agent and reducing agent can be combined with the filler and kept in a storage-stable state. Likewise, through appropriate selection of a water-insoluble encapsulant, the reducing agent and oxidizing agent can be combined with water and the acidic polymer and maintained in a storage-stable state.
Hither water-soluble or water-insoluble encapsulants can be employed. However, water-insoluble encapsulants are preferred, as they generally provide better long term storage stability under moist or humid conditions. Although the use of a water-insoluble encapsulant may initially seem inappropriate in a water-based cement, it has been found that vigorous I5 mechanical mixing generally will be sufficient to break apart the capsule walls and permit adequate release of the encapsulated reducing agent or oxidizing agent and subsequent cure of the cement.
Preferably the encapsulant is a medically acceptable polymer and a good film former. Also, the glass transition temperature (Tg) of the encapsulant preferably is above room temperature.
A wide variety of encapsulants can be used, with cellulosic materials as cellulose acetate, ' 25 cellulose acetate butyrate, ethyl cellulose, , hydroxymethyl cellulose and hydroxyethyl cellulose being preferred: Other encapsulants include polystyrene, copolymers of polystyrene with other vinylic monomers, polymethylmethacrylate, copolymers of methylmethacrylate with other ethylenically-unsaturated monomer's, and other materials that will be familiar~to those skilled in the art of encapsulation.
The capsules themselves need not be perfectly spherical nor uniformly shaped. It~is merely sufficient that they entrain or entrap the encapsulated reducing agent or oxidizing agent in a manner sufficient to permit storage of the encapsulated CJ ~ -12 material in a cement component without leading to undesirable premature polymerization.
To encapsulate the reducing agent or oxidizing agent in a water-insoluble encapsulant, it is preferred to dissolve the encapsulant in a suitable water-immiscible solvent such as methyl acetate, ethyl acetate or methylene chloride. Meanwhile, the reducing agent or oxidizing agent is dissolved in water. The water solution can then be added to the solution of l0 encapsulant arid water-fmmiscible solvent. stirring or other high speed shear techniques preferably are used to promote uniform microcapsule formation. The capsule shells are formed around the aqueous solution droplets either by evaporation of the water-immiscible solvent or by the addition of a secand water-immiscible solvent (e. g., n-hexane) that will precipitate the encapsulant.
The capsules can then be removed by cooling and filtration. "
To encapsulate the reducing agent or oxidizing agent in a water-soluble encapsulant, the dry reducing agent or oxidizing agent is preferably suspended in a stirred solution of the encapsulant in a water-immiscible organic solvent. Vigorous stirring will promote uniform encapsulation of the reducing agent or oxidizing agent: The capsules can be formed by evaporation or by precipitation and then removed using the techniques described above.
If desired, the cements of the invention can contain adjuvants such as pigments, nonvitreous fillers, inhibitors, accelerators, viscosity modifiers, surfactants; amd otheringredients that will be _ apparent to those skilled in the art.
The cements of the invention can be mixed and clinically applied using conventional techniques.
However; the cements will have particular utility in clinical applications where cure of a conventional light-curable cement may be difficult to achieve. Such WO 92/21314 n P~'1'/US92104164 '-13-applications include deep restorations, large crown build-ups, endodontic restorations, luting of metallic crowns or other light-impermeable prosthetic devices to teeth, and other restorative applications in inaccessible areas of the mouth. The three-way cure mechanism facilitates thorough, uniform cure and retention of goad clinical properties. The cements of the invention thus show good promise as a universal restorative.
l0 The cements of the invention are further described in the following illustrative examples, which should not be construed as limiting the scope of the invention. Unless otherwise indicated, all parts and percentages are on a weight basis.
EZliMPLE
cements preparsd oeing'V'arioua Curiag Modes A test solution was prepared by combining the ingredients set out below in Table Ia:
Table =a =ngrodiants pants Acrylamide 30 Methylene bis-acrylamide 3 2 5 Water 3 0 ~
In a series of four runs a 2g portion of the test solution was placed in a glass test tube. For each 30 run, 2% of the, ingredients set out below in Table Iby were added to a separate test tube with shaking:
wo ~2iz~~m ~criu~h2ia4~ba ~1~
Table ~b ' ~,ur~ ~o. ~ lead~d x~agrgd3.e~ats 1 Potassium Persulgate As~:orbic Acid 2 Potassium Peraulfate Thiourea 3 Potassium PersulEate Oxalic Acid 4 Ammonium .Persulfate Ascorbic Acid The contents of the two test tubes were combined with shaking. Far each run, gelation and an exotherm were observed within seven minutes.
The ingredients set out below in Table IIa were mixed, melted in an arc furnace at about 1350-1450°C, poured from the furnace in a thin stream and quenched using chilled rollers to provide an amorphous single-phase fluoroaluminosilicate glassy Table IIa Ingredient gart~
Si0 3?
AlF 23 SxO 20 A1~0~ 10 Na A1F 6 ., ,, p Q 4 The glass was ball-ma.Iled to provide a pulverized frit with a surface area of 2.6 m2/g measured using the Brunauer, Emmet and Teller (BET) method. The pulverized glass was labeled "Control Glass". 20 Parts swo 9xizma ~criu~~z~n4ma _,.5- 2110~~~
of the Control Glass were mined with a solution of 0.1 parts ascorbic acid (a water=soluble reducing agent) in 39.5 parts methanol, and stirred for 10 minutes using a magnetic stirrer. The wet glass was poured into a dish to a depth less than 1 cm, and then dried in a 45°C
oven for 16 hours. The dried glass was sieved through 3 74 ~Cm mesh screen, and labeled "Glass A".
The ingredients get out below in Table IIb were mixed using a paint shaker to provide two cement-forming liquids labeled "Control Liquid" and "Liquid A". Each liquid contained ethylenically-unsaturated components (as groups on the copolymer and as a separate ingredient), and carboxylic acid (as groups on the copolymer). Liquid A also contained potassium persulfate (a water-soluble oxidizing agent):
Table IIIa .,~ _ ~ T, Cement-forming liquid~r, parts ~'~'~' Ingredient ""'-Control Liquid Liquid i~
Copolymers 50 50 Water2 30 30 HEr~A~ 2 a 2 0 C H ) I'~PF - 0 . 7 0 . 7 CP~4 ' 0.25 0.25 BHT~ 0.1 0.1 K S O -'-- 0.05 Ethylenically-unsaturated acidic copolymer prepared like the precipitated dry polymer of 3C) EXAMPLE 1l of European Published Pat. Application:
No. 0 323 120.
Distilled water.
2-Hydroxyethyl methacrylate.
Camphorquinone.
5 Butylated hydroxytoluene.
WU 92121314 PGTlUS92/04164 -3.f-The absorbic acid-treated Glass A and the potassium persulfate-containing Liquid~l~ were hand-spatulated at a x..4:1 powder: liquid ratio. The resulting cement exhibited good mixing properties and a two minute working time. The end of the working period coincided with a loss of glass and a marked decrease in tack.
In a series of 4 runs, the glasses Control Glass and Glass A, and the liquids Control Liquid and Liquid A, Were hand~spatulated for one minute at a l0 1.4:1 powder:liquid ratio, then packed into a 4 mxn inside diameter glass tube, capped with silicone rubber plugs, and axially campressed at about 0.28 ~lPa. About Z.5 minutes after the start of mixing, samples for the cements of Runs nos. ~, and ~ were exposed for 80 seconds to light from two oppositely-disposed visible light curing lamps ("VISILUX 2" curing lamp, 3M~ and then the axial pressure was removed. The cements of Run nos. 2 and 4 were allowed to remain under pressure for 10 minutes and were not photopalymerixed.
Eaah of the cements of Run nos. 1-4 was allowed to stand for one hour at ambient pressure, 90%+
relative humidity and 37°C. The samples were cut on a diamond saw to form cylindrical plugs 2 mm long for measurement of Diametral tensile strength ("DTS"), and 8 mm long for'measurement of compressive strength ("CS"). The plugs were stored in distilled Water at approximately 3?°C for'about 24 hours. DTS and CS
values were determined for 5 samples of each cement according to ISO specification 7489.
The results are set out below in Table III,.
along with a brief id'en'tification of the~applicable cure mechanism far each sample.
._.__._._...___._...._......._...,...»...,. ;i..,.::. :-:~..:-..~ ~.~.:._u~~:
. .':~:.'...,f......,.,... 1 ,,.~r'~. ,.. ~':.._,:, ...v..v wo ~z~za3a4 Pcrius~zioaa~a ~1'~ ~1~~.(~~')'~
m~t~ie ~C1I
Run Glass Liquid Photo Cure CS D~,S_ No. Curing Mech-anism _"~"~"~
1 Glass Liquid Yes IPR~ 154 27 A
A
2 Glass Liquid No TRz 141 20 A
A
3 Control Contxol Yes TP3 155 26 Glass Liquid 4 Control Control No T4 37 3 Glass Liquid ~~IPR" = Acid-base ionomer reaction ("I") plus photoinitiated reaction ("P") plus redox reaction ("R").
"IR" - I reaction plus R reaction.
"IP" - I reaction plus P reaction.
4 ~'I" - I reaction.
The results in Table IIT illustrate the improvement provided by the invention. When a cement of the invention was cured using all three cure mechanisms (Run no. 1), CS and DTS were experimentally equivalent to the values obtained for a light-curable ionomer cement cured in thin section using two cure mechanisms (Run no. 3). When the photoinitiated "P" mechanism was omitted but the redox "R" reaction was present (Run no.
2), CS and DTS were maintained at respectably high levels. This would correspond to curing a cement of the invention in a very thick section, or to curing it without a properly-operating curing lamp. With or ,' without photocur~ing, the cement of the invention had substantially better CS and DTS than a cement cured using only the ionomer '°I" reaction (Run no. 4). Thus a cement of the invention could be cured without a curing lamp, or with a defective curing lamp, and still provide a strong cured Dement.
wc~ ~zizi3aa wcrms~aioaaba '~1~. ~~3 -~8r ~n a further comparison, the Control Liquid was combined with 0.05% benzoyl peroxide and shaken on a paint mixer for two days. The peroxide did not dissolve, demonstrating that a water--soluble oxidizing agent was required even though the Control Liquid contained a substantial portion of nonaqueo~us resin.
E~LAM~'9L~: 2 Gomparix~aa of ~e;ntin ~dheeioa Usiac~ 'Vaxxis~ug Gux~.ag Modea Five bovine teeth of similar age and appearance were partially embedded in circular acrylic disks so that the enamel was exposed. The exposed portion of each tooth was ground flat and parallel to the acrylic disc using Grade x.20 silicon carbide paper-backed abrasive mounted on a lapidary wheel, until the dentin was exposed. Further grinding and polishing of the teeth was carried out by mounti,ngw Grade 320 silicon carbide p~perbacked abrasive on the lapidary wheel. During the grinding and palishing steps, the teeth were continuously rinsed with water.
The polished teeth were stored in distilled water and used for testing within 2 hours after polishing. Tyke polished teeth were removed from the water and dried using a stream of compressed air.
~r mold made from a 2.5 mm thick °°TEFLON"
polytetrafluoroethylene sheet with a 5 mm diameter circular hole through the sheet was clax~ped to each polished taoth so that the central axis of the hole in the mold was normal to the polished tooth surface. The mold was fitted with'a sleeve made from a no. 4 gelatin capsule. The sleeve was filled with a hand-spatulated glass ionomer cement mixture. The cement was bight-cured for 60 seconds, allowed to stand for about 5 minutes at room temperature, then stored in distilled water at 37pC for 24 hours, Dark-cured samples were WU 92!21314 PCT/LJ592/04164 not photocured, but were allowed to stand at room temperature under a yellow safelight for 15 minutes before placing them in water. The molds were then carefully removed, leaving a molded cement button attached to each tooth.
Adhesive strength was evaluated by mounting the acrylic disk in a holder clamped in the haws of an "INSTRON" tensile testing apparatus with the polished tooth surface oriented parallel to the direction of 1.0 pull. A loop of 0.44 mm diameter orthodontic wire was placed around the base of the cement button adjacent to the polished tooth surface. The ends of the orthodontic wire were clamped in the pulling haw of the tensile testing apparatus, placing the bond in shear stress. The bond was stressed until it (or the cement button) failed; using a crosshead speed of 2 mm/min and an average of 5 or more samples,.
A freshly-mixed sample made from a x.4:1 mixture of Glass A and Liquid A was evaluated for adhesion to dentin using the procedure described above.
With photocuring, the average measured adhesive shear bond strength for 6 samples was 8.9 MPa. °If photocuring was omitted, the average measured shear bond strength dropped to 2.9 MPa. A control cement prepared from the Control Glass and the Control Liquid had an avexage measured adhes3.ve shear bond strength of 4.6 MPa. If photocuring was omitted, the average measured adhesive shear bond strength dropped to less than l MPa: Accordingly, use of a cement with all three cure modes yielded the highest average dentin .
adhesion.
Dark (non-photopolymerized) set time was evaluated using a modified version of ISO standard ?489. The measurement was performed under a yellow safelight at 21-23nC, and resistance to indentation by a 400 g Gilmore needle was evaluated 60 seconds after the start of mixing and every 10 seconds thereafter.
...,........ z.... _., ............. .. ..,,..., ..aK.,:~. ;-', . t;-...,e.~..r. n..... ,...,, .:~'_~.:., ,. ..,.", ....~..:..," ... !-.::_... "
~.... . . . , . ..., W~ 12/21314 PCT/US92l04164 ~~~u~~~
-zo-The cement of the invention had a set time of 11.5 minutes, and the control cement had a set time greater than 36 minutes.
E7D1MP~E 3 preparation of Pow~lere Containing ~cidixing and Reduoing Agents A sample of the untreated Control Glass was slurry-treated with 0.1% potassium persulfate using the method of EXAMP1~E 1. The treated glass was labeled "Glass E". A further sample of the Control Glass was slurry-treated with 0.5% ascorbic acid. The treated glass was labeled "Glass C". Equal portions of Glass B
and Glass C were hand-mixed to provide a dry glass l5 containing both an oxidizing agent and a reducing agent. This glass was labeled '°Glass D".
When Glass D and the Control Liquid were combined in a 1.4:1 powder: liquid ratio and evaluated using the method of EXAMPLE 1, a cement with a CS of 152 MPa and a DTS of 28 Mria was obtained. The cement had an average measured adhesive shear bond strength of 7.8 MPa.
EXAMPLE 4 ' Dements ,prepared from Liquids Containing oxidiziag Ag~nt and powdera~ CAntaining Realuaing Ag~nt Several liqu3.d solutions were prepared from the ingredients set out blow in Table IVa:
WO 92/21314 Pcr~us92~u4164 Table IVa esmaa~rss~~wmieras, ,~.~....~
=ngreaieat parts ...' ys ~s ~
Copolymer of EXAMPLE 1 w Water 30 H~ 20 (C H ) I~PF " 0.?
CPQ 0.25 HHT 0.10 K S O See Table IVb Several portions of a glass like the Control Glass of EXAMPLE I (but with a surface area of 3.3 m2/g) were slurry-treated with variQUS methanolie ascorbic acid solutions: The theoretical amounts of ascorbic acid on the treated glass are set out below in Table IVb.
Cements were formed by combining the treated glasses and liquids at a 1.4:1 powder: liquid ratio.
Dark set times were tested according to ISO standard DIS 991?, using a 400 g indenter. Approximately 30 seconds were required to xa~x the cement, transfer it t4 the mold specified,in the ISO standard, and place the mold in a 3?°C oven (also specified in the ISO
standard). ay then, some of the faster cements had already begun to set. These set times are indicated as "530" in Table IVb.
r ..i'.~.4~ : 6. .
-0 ' PT
S ' r . . . .. ._ ..", . ..., .,. . . ,, .. . . . r .. . . . .. 4 . . . n .. , . ... w _... ..... ._...~__._ ........... _.... .... ..... , .~ ~_. . ...~.<.
r.r....::.a.....a.,.;r>...~;r~~.r,.....,.... ... ...;,.. , . . ... ,., .. ....
, . .,. ..~ ..".. . . , WU 92/21314 ~GTlUS92/04164 Tahle~IVb =BO' BET Time~sea (dark) L
% 1C BZOe % Aacorbia Aaid on Gilass in L~quid o.os o.ia a.2~ o.s s,.o i.s ~.o 0.025 600 400 360 280 240 120 100 0.05 330 280 230 120 80 ?0 80 0.10 -_ 160 ?0 50 50 40 40 0.25 -_ 100 50 40 40 S30 530 0.5 _- _~- __ 40 35 35 35 1.0 __ _ __ 35 530 35 35 1.5 _-- __ --~ 530 530 X30 530 2.0 I _ __ ' ~'~ ~ 35 I S30 I 530 ~ 530 m~~ a~~ a The above data shows dark set times for cements ,.
containing varying amounts of reduc~.ng agent and oxidizing agent. The range of observed set times varied more than twenty_fold. Since the ISO test is performed at an elevated temgerature (3?°C)~, room temperature set times likely would be longer.
EBAM>'LE 5 Cements prspsrad from Liquids contaiaing o~cidiziag Ageat and =ahibitor The following liquid solutions were prepared:
WU 92/2!314 PCI'/US92/04164 ~~.~.o~J~
m~.s,i A v Par ts Ingrallient Doatrol Liquid Liquie! Liquid Liquid 2 8 Copolymer of 100 100 100 100 Water 60 60 60 60 CPQ 1.0 1.0 1.0 1.0 HHT 0.1 0.1 0.1 0.1 K S O 0.05 0.05 0.05 0.05 t 4-methoxyphenol - 0.1 0.5 1.0 ~.5 The untreated glass used in EXAMPLE 4 was slurry-treated by mixing together the ingredients set out below in Table VI. Each slurry was poured into a ..
plastic-lined tray, dried overnight at 45°C, and then sie~red through a ?4 ~cm mesh screen to make Glasses E, F
and G.
Tsbie va Parts ' =agredisat Glass E Glaas F ~ilsss ci methanol 40 40 40 glass powder 20 20 20 diphenyliodonium 0.40 0.40 0.40 chloride ascorbic acid , ~ 0.01 0.02 0.05, 3p Dark set times were determined using the method of EXAMPLE 4. The results are set out below in Table VII.
WO 92!21314 PCTlUS92l04164 2~.1~~~~ -24- , Tahle VI2 ;~- s~.~
nark get time, seoonds Glass E Glass'F Glass G
Control Liquid 2 330 280 230 Liquid B 870 840 510 Liquid C 930 840 810 Liquid D 900 870 810 The above data shows that adding 4-metho~cyphenol can to increase set times, thus providing some measure of control over polymerization.
E~pL1 6 cement prepa~rsa Osiag Thiourea as R.duaing Agent 20 Parts of the untreated glass of EXAMPLE 4 were slurr3.ed for 30 minutes in a solution of 0.15 parts thiourea in 40 parts methanol. The treated glass was dried overnight at 45°C and sieved through a 74 ~Cm mesh screen. A liquid solution was prepared from the ingredients set out below in Table VIII:
TahIA VIII
Ingrraieat Bans ~ --.-._,._ 50 ~
Copolymer of EXAMPLE 1 Water 30 ~ C H ~ - I+pF ' 1. 0 CpQ 0.25 BHT ' . 0.10 K S O 0.05 Cement mixes were prepared at a 1.4:1 powder:~liquid ratio, placed in the IS0 9917 mold described in EXAMPLE 4, and photocured from above for 60 seconds ewU ~~/2~ m a n~rius~z~om 6a _25_ ~1~.0~59 using a VISILUX 2 dental curing light. "Barcol"
hardness values were determined using a Barber-Colman hardness tester and indenter "G~lZJ935". The measured hardness values were 51 on the top and 4S on the bottom of the molded cement sample, indicating that very uniform cure was obtained.
EX~iMPLE 7 Dement prepar~d from a Liquid Dontaining 'Polys~arbo~cyl~irs l0 Acid pithout Pendant Htbylania t~nsaturation A liquid salution containing a separate ethylenically-unsaturated ingredient was prepared by mixing together the ingredients set out below in Table IX:
Table I~
=ngrediant Barts~
L
33% solution of polyacrylic 6 acid ( ~25,OOOa in water 2 0 IiEMA 4 UDMAl 0 . 3 GDMAZ 0.3 Trimethylhexamethylene diisocyanate end-capped at a 2:1 molar retie with HEMA
Glyceryl dimethacrylate A mixture of 0.g parts Glass H and 0.8 parts Glass C
was hand-spatulated with l part of the liquid. Using the method of EXAMPLE 2,, a dark set time of 10 minutes, 10 seco~ids was observed.~t The average of the top and bottom Barcol hardness values after 1 hour was 43.
A control cement was prepared by mixing 1.6 parts of the untreated Control Glass with 1 part of the liquid. A dark yet time of 50 minutes was observed.
The average of the top and bottom Barcol hardness values after 1 hour was only 9.
u,.,; . ; : . ", . ,. ,.,., .., wc~ ~ziz~3~4 r~criU~h2~oa~6a EXI~P~E 8 Mi~cture of Commercial Cement Liquid with powder Containing oxidizing Agent and Reducing Agent 1 Part "GC Fuji LC" Liquid (the liquid portion of a commercial light-curable glass ionamer cement from GC Corp.) was hand-spatulated with 1.4 parts Glass 1~ (which was made by combining 0.7 parts of the potassium persulfate-treated Glass B and 0.7 parts of the ascorbic acid-treated Glass C). Using the method of EXAMPLE 7, a dark set time of 10 minutes and an average Barcol harness after 2 hours of 72 were observed.
A control cement was prepared by hand-spatulating 1 part GC Fuji LC Liquid with the untreated Control Glass and stored under a yellow safelight.
After ~. hour and 45 minutes, the mixture had not set.
This example demonstrates that a commercial light-curable glass ionomer cement can readily be modified to improve its dark set time.
Microenaapsulation of Kx8208 in Cellulose Aoetate Butyrate (CAB) 8.0 Parts CAB containing 18% butyl groups ' were dissolved in 800 parts methylene chloride.
Separately, 5.0 parts KaSxOg were dissolved in 200 parts water. 330 Parts of the methylene chloride solution were transferred to a stainless steel vessel suspended in a room temperature water bath. A stirring impeller was suspended in the vessel and spun at 700 rpm. To .
the stirred solution was added 50 parts of the KZS2Og solution. The temperature of the water bath was raised to 37-38°C, thereby slowly evaporating the methylene chloride. After one-half hour, ice was added to the water bath to lower the temperature to 24°C. 165 Parts n-hexane were added slowly to the vessel in order to precipitate the encapsulated oxidizing agent. The ~2,/w precipitate was filtered, washed with cold n-hexane and dried under vacuum. The resulting dry microcapsules were deagglomerated in an electric coffee grinder, yielding a very light fluffy powder.
E,PLE
Fonder Containing Microenaapgulated oxidizing Agent and Unenaapaulat~d Reducing Agent 67 Parts of the untreated glass used in EXAMPLE 4 were mixed on a roll mill for 2 hour with 0.232 parts of the microcapsules of EXAMPLE 9. 20 Farts of the resulting treated glass were mixed on a ..,.~
roll mill for ane-half hour with 20 parts of a fresh sample of Glass C. The resulting mixture was labelled "Glass H". 2t was combined at a 1.4:1 powder: liquid ratio with Control Liquid 3 (a liquid like the Control Liquid of EXAMPLE 1, but containing 1 part rather than 0.7 parts (C6H5)2I*PF6 ) and evaluated using the method of EXAMPLE 2. A set time of 12.5 minutes was observed.
Portions of Glass H were subjected to accelerated aging for 4 days and 8 days at 45°C. Set time measurements showed that the dark curing reaction was not slowed, thus indicating that the microcapsules had excellent storage stability.
EBAMPTrE 11 Miaroencapaulation of Ascorbic Acid in CAB
3 Parts ascorbic acid were dissolved in 60 parts water. 8 Parts CAB,were dissolved in 800 parts dichloromethane. 330 Parts of the CAB solution and 5.0 parts c~f the ascorbic~~acid solution were added to a' stainless steel vessel and stirred at 708 rpm. A
38-40°C water bath was placed under the vessel. 165 Parts n-hexane were added slowly to the stirred mixture 35. over a one-half hour period. A granular precipitate formed. stirring was continued for 15 additional minutes. The warm water bath was replaced with an 'WO 92/Z 1314 PCT/ US~12104164 -zs~-ice~water bath, resulting in the formation of additional precipitate. The~precipitate was ffiltered, washed with n-hexane and dried under vacuum. The dried product was ground to a fine powder.
EBJ'~MPLB ~.2 8ila~aol-°~reated t~la~es Ponder Cont~aiu~.ng Mir~roenoapsulrated ~cx~~t~g, and as~~rb~,c~ Aaid 4 Parts "A-174" gamma~methacryloxypropy~.
trimethoxysilane (Union Carbide Carp.), 25 parts methanol, and 25 parts water were mixed, then acidified with trifluoroacetic acid until the pH reached 3.9.
The mixture was stirred for 25 minutes at roam temperature, yielding a silanol,--contafining treating solution. 1,00 Parts of a glass like the Control Glass of EXAMPLE 1 (but having a surface area of 2.8 M2/g rather than 2.6 M2/q) were combined with the silanal treating solution, slurried for 1.5 hours at room temperature, dried overnight at 45°C, and sieved through a 74 ~m mesh screen. A portion of the treated powder (5 parts] was mixed with 0.012 parts of 'the microencapsulated potassium persulfate of EXAMPLE 9.
Another portion of the treated powder (5 parts) was mixed with 0.06 parts of the microencapsulated ascorbio acid of EXAMPLE 11. The two powder portions were combined and then r~11-m3.lled for one-half hour. The resulting blended powder was combined at a 2.2:1 powder: liquid ratio with Control Liquid ~ (a liquid like Control Liquid 3, but containing 0.05 parts BHT
rather than 0.1 parts). The resulting cured cement was evaluated fgr CS and I7TS using the method of EXAMPLE 1 (but with a 60 second photocure rather than 80 seconds). The respectfive CS and DTS values were 195 MPa and 38 MPa. Lf photocuring was omitted, the respectfive CS and DTS values were 180 MFa and z5 MPa.
Adhesion to enamel was evaluated by generally following the procedure of EXAMPLE 2. However, the WU '~~1Z1314 PC1'/US92/04164 21~.~~~9 potted teeth were ground to expose only the enamel surface. The polished enamel surface was etched far 15 seconds using gelled 37% phosphoric acid, washed far 30 seconds with water and then dried using compressed air.
The measured adhesion to etched enamel was ~.8 MPa.
EXAMPLE ~,3 Miaroencapsula~tion by x~reaipitative Method The three separate solutions whose compositions are set out below in Table X ware each placed in separate addition funnels:
~~~~~ g Run ~to. Solution 1 3 parts ascorbic acid in 60 parts water 2 3 parts K S O in 60 parts water 3 3 parts (NH y S O in 60 parts water Tn a series of three separate runs, 50 parts of one of the solutions shown above were added to 366 parts of a stirred 1% solution of CRB in ethyl acetate contained in a stainless steel vessel immersed in a 4°C water bath. The stirrer speed Haas maintained at 700 rpm and the bath temperature was maintained at 4°C. 267 Parts of ice cold n-hexane were added dropwise to the stirred solution over a 30 minute period. Granular spherical microcapsules were formed, as evidenced by microscopic examination: Stirring was continued for an additional 15-minutes: The granular~precipitate was filtered,;
washed with ice-cold n-hexane, dried under vacuum and then deagglomereted in ;an electric coffee mill.
WCl X2121314 PCI'lUS92/04164 ~30~
EXAMPLE ~.4 Preparation of Tri-Cure Cement from 8ilanol~~Treated ~3laes Powder To 100 parts of a silanol~treated glass like that of EXAMPLE 12 were added 0.55 parts of the ascorbic acid microcapsules of Run no. 1 of EXAMPLE 13, and 0.i parts of the K2S20g microcapsules of Run no. 2 of EXAMPLE 13. The mixture was mixed on a roll mill for 1 hour. Using the method of EXAMPLE 4, the dark l0 set time was determined to be 4 minutes, 20 seconds.
Using the method of EXAMPLE 12, the respective CS and DTS values after light-curing were determined to be 210 MPa and 31 MPa.
EB~1MPLE Z 5 preparation of Tri-Cure Cement from Miaroenaapeulated (NH4~aSZ~8 and Asoorbia Aaid A solution of 2 parts A1?4 silane, 12.5 parts methanol, 12.5 parts water and 0.22 parts acetic acid was stirred for 30 minutes, combined with 50 parts of the untreated glass of EXAMPLE 12, slurried for 1.5 hours at room temperature, dried overnight-at 45°C, and sieved through a ?4 hem mesh screen.
20 Parts of the resultant powder were added to 0.11 parts'of ,the microencapsulated ascorbic acid of Run no. 1 of EXAMPLE 13 and 0.02 parts of the microencapsulated ammonium persulfate of Run no. 3 of EXAMPLE 13. The powders were mixed by roll.-milling for about 1 hour. When evaluated as in EXAMPLE 14, the dark set time was determined to be 4 minutes, 20 seconds, and the CS and DTS values were 'determined to be 20S MPa and 30 MPa.
Modification of Commercial Cements In a first run, 4.5 parts "GC Fuji LC" light-curable glass ionomer cement were combined with 0.025 WO 92/21314 ~ ~ ~ ~ ~ ~ PC'1'/US92/04164 _31_ parts of the ascorbic acid microcapsules of Run no. 1 of EXAMPLE 13 and 0.0045 parts of thd potassium persulfate microcapsules of Run no. 2 of EXAMPLE 13.
The resulting powder mixture was roll-milled for one half hour. The powder was labeled "Modified GC Glass".
As a second run, 4.1 parts "Kerr XR" ionomer powder (Kerr Division of Sybron, Inc.) were combined with 0.0336 parts of the ascorbic acid microcapsules and 0.0044 parts of the potassium persulfate l0 microcapsules. After roll-milling, the resulting powder was labelled "Modified Kerr Glass".
The modified glasses and the unmodified commercial glasses were independently combined at a 1.4:1 powder: liquid ratio with the corresponding commercial liquids supplied by the manufacturers, and permitted to harden without photocuring. The resulting cements were evaluated for room temperature and ISO
dark set time using the methods of EXAMPLES 2 and 4:
The cements were also evaluated for Barcol hardness using the method of EXAMPLE 6. Set out below in Tables XIa and XIb are the set time and Barcol hardness ~ralues for each cement.
Table XIa ac cement 0n~nodified Modiffea Dark Set Tiale' Room Temperature 35 min 12 min 30 sec ISO (37C) 8 min 40 sec 5 min 20 sec Harcol Hardae8s ~ . ~. . ' ~ r Room'Temperature .. 30 After 15 minutes 0 23 After one hour 15 47 ISO (37C) After 15 minutes 22 22 After one hour 34 54 WU 92/21314 PGfi/US92/041G4 _3Z_ Table alb Kerr cement Onmodified Modified Dark Sot Timo Room Temperature 35 min 12 min 30 sec ISO (37C) ~ 14 min 5 min ~o sec Haraol 8ardn~ss Room Temperature After 15 minutes 0 0 After one hour 0 24 ISO (37C) After l5 minutes 0 0 After one hour ~ 8 f 34 As the above data illustrates, under dark conditions the modified cements set more rapidly and reached a higher ultimate hardness than the unmodified cements.
The modified cements would therefore be much better suited to deep cure restorations, cure without a light or with a faulty light, and other low light situations.
Although this invention has been described ' using certain illustrative examples, it should -be understood that the invention is not limited to the specific exemplary embodiments shown in this specif ication:
__. ..~...... .... .. r... ...... .. . ..., , ,. .. F~... a.. ., , .... ,f..:~
. . ;:.~,. . ,. . . .,
WU 92121314 PGTlUS92/04164 -3.f-The absorbic acid-treated Glass A and the potassium persulfate-containing Liquid~l~ were hand-spatulated at a x..4:1 powder: liquid ratio. The resulting cement exhibited good mixing properties and a two minute working time. The end of the working period coincided with a loss of glass and a marked decrease in tack.
In a series of 4 runs, the glasses Control Glass and Glass A, and the liquids Control Liquid and Liquid A, Were hand~spatulated for one minute at a l0 1.4:1 powder:liquid ratio, then packed into a 4 mxn inside diameter glass tube, capped with silicone rubber plugs, and axially campressed at about 0.28 ~lPa. About Z.5 minutes after the start of mixing, samples for the cements of Runs nos. ~, and ~ were exposed for 80 seconds to light from two oppositely-disposed visible light curing lamps ("VISILUX 2" curing lamp, 3M~ and then the axial pressure was removed. The cements of Run nos. 2 and 4 were allowed to remain under pressure for 10 minutes and were not photopalymerixed.
Eaah of the cements of Run nos. 1-4 was allowed to stand for one hour at ambient pressure, 90%+
relative humidity and 37°C. The samples were cut on a diamond saw to form cylindrical plugs 2 mm long for measurement of Diametral tensile strength ("DTS"), and 8 mm long for'measurement of compressive strength ("CS"). The plugs were stored in distilled Water at approximately 3?°C for'about 24 hours. DTS and CS
values were determined for 5 samples of each cement according to ISO specification 7489.
The results are set out below in Table III,.
along with a brief id'en'tification of the~applicable cure mechanism far each sample.
._.__._._...___._...._......._...,...»...,. ;i..,.::. :-:~..:-..~ ~.~.:._u~~:
. .':~:.'...,f......,.,... 1 ,,.~r'~. ,.. ~':.._,:, ...v..v wo ~z~za3a4 Pcrius~zioaa~a ~1'~ ~1~~.(~~')'~
m~t~ie ~C1I
Run Glass Liquid Photo Cure CS D~,S_ No. Curing Mech-anism _"~"~"~
1 Glass Liquid Yes IPR~ 154 27 A
A
2 Glass Liquid No TRz 141 20 A
A
3 Control Contxol Yes TP3 155 26 Glass Liquid 4 Control Control No T4 37 3 Glass Liquid ~~IPR" = Acid-base ionomer reaction ("I") plus photoinitiated reaction ("P") plus redox reaction ("R").
"IR" - I reaction plus R reaction.
"IP" - I reaction plus P reaction.
4 ~'I" - I reaction.
The results in Table IIT illustrate the improvement provided by the invention. When a cement of the invention was cured using all three cure mechanisms (Run no. 1), CS and DTS were experimentally equivalent to the values obtained for a light-curable ionomer cement cured in thin section using two cure mechanisms (Run no. 3). When the photoinitiated "P" mechanism was omitted but the redox "R" reaction was present (Run no.
2), CS and DTS were maintained at respectably high levels. This would correspond to curing a cement of the invention in a very thick section, or to curing it without a properly-operating curing lamp. With or ,' without photocur~ing, the cement of the invention had substantially better CS and DTS than a cement cured using only the ionomer '°I" reaction (Run no. 4). Thus a cement of the invention could be cured without a curing lamp, or with a defective curing lamp, and still provide a strong cured Dement.
wc~ ~zizi3aa wcrms~aioaaba '~1~. ~~3 -~8r ~n a further comparison, the Control Liquid was combined with 0.05% benzoyl peroxide and shaken on a paint mixer for two days. The peroxide did not dissolve, demonstrating that a water--soluble oxidizing agent was required even though the Control Liquid contained a substantial portion of nonaqueo~us resin.
E~LAM~'9L~: 2 Gomparix~aa of ~e;ntin ~dheeioa Usiac~ 'Vaxxis~ug Gux~.ag Modea Five bovine teeth of similar age and appearance were partially embedded in circular acrylic disks so that the enamel was exposed. The exposed portion of each tooth was ground flat and parallel to the acrylic disc using Grade x.20 silicon carbide paper-backed abrasive mounted on a lapidary wheel, until the dentin was exposed. Further grinding and polishing of the teeth was carried out by mounti,ngw Grade 320 silicon carbide p~perbacked abrasive on the lapidary wheel. During the grinding and palishing steps, the teeth were continuously rinsed with water.
The polished teeth were stored in distilled water and used for testing within 2 hours after polishing. Tyke polished teeth were removed from the water and dried using a stream of compressed air.
~r mold made from a 2.5 mm thick °°TEFLON"
polytetrafluoroethylene sheet with a 5 mm diameter circular hole through the sheet was clax~ped to each polished taoth so that the central axis of the hole in the mold was normal to the polished tooth surface. The mold was fitted with'a sleeve made from a no. 4 gelatin capsule. The sleeve was filled with a hand-spatulated glass ionomer cement mixture. The cement was bight-cured for 60 seconds, allowed to stand for about 5 minutes at room temperature, then stored in distilled water at 37pC for 24 hours, Dark-cured samples were WU 92!21314 PCT/LJ592/04164 not photocured, but were allowed to stand at room temperature under a yellow safelight for 15 minutes before placing them in water. The molds were then carefully removed, leaving a molded cement button attached to each tooth.
Adhesive strength was evaluated by mounting the acrylic disk in a holder clamped in the haws of an "INSTRON" tensile testing apparatus with the polished tooth surface oriented parallel to the direction of 1.0 pull. A loop of 0.44 mm diameter orthodontic wire was placed around the base of the cement button adjacent to the polished tooth surface. The ends of the orthodontic wire were clamped in the pulling haw of the tensile testing apparatus, placing the bond in shear stress. The bond was stressed until it (or the cement button) failed; using a crosshead speed of 2 mm/min and an average of 5 or more samples,.
A freshly-mixed sample made from a x.4:1 mixture of Glass A and Liquid A was evaluated for adhesion to dentin using the procedure described above.
With photocuring, the average measured adhesive shear bond strength for 6 samples was 8.9 MPa. °If photocuring was omitted, the average measured shear bond strength dropped to 2.9 MPa. A control cement prepared from the Control Glass and the Control Liquid had an avexage measured adhes3.ve shear bond strength of 4.6 MPa. If photocuring was omitted, the average measured adhesive shear bond strength dropped to less than l MPa: Accordingly, use of a cement with all three cure modes yielded the highest average dentin .
adhesion.
Dark (non-photopolymerized) set time was evaluated using a modified version of ISO standard ?489. The measurement was performed under a yellow safelight at 21-23nC, and resistance to indentation by a 400 g Gilmore needle was evaluated 60 seconds after the start of mixing and every 10 seconds thereafter.
...,........ z.... _., ............. .. ..,,..., ..aK.,:~. ;-', . t;-...,e.~..r. n..... ,...,, .:~'_~.:., ,. ..,.", ....~..:..," ... !-.::_... "
~.... . . . , . ..., W~ 12/21314 PCT/US92l04164 ~~~u~~~
-zo-The cement of the invention had a set time of 11.5 minutes, and the control cement had a set time greater than 36 minutes.
E7D1MP~E 3 preparation of Pow~lere Containing ~cidixing and Reduoing Agents A sample of the untreated Control Glass was slurry-treated with 0.1% potassium persulfate using the method of EXAMP1~E 1. The treated glass was labeled "Glass E". A further sample of the Control Glass was slurry-treated with 0.5% ascorbic acid. The treated glass was labeled "Glass C". Equal portions of Glass B
and Glass C were hand-mixed to provide a dry glass l5 containing both an oxidizing agent and a reducing agent. This glass was labeled '°Glass D".
When Glass D and the Control Liquid were combined in a 1.4:1 powder: liquid ratio and evaluated using the method of EXAMPLE 1, a cement with a CS of 152 MPa and a DTS of 28 Mria was obtained. The cement had an average measured adhesive shear bond strength of 7.8 MPa.
EXAMPLE 4 ' Dements ,prepared from Liquids Containing oxidiziag Ag~nt and powdera~ CAntaining Realuaing Ag~nt Several liqu3.d solutions were prepared from the ingredients set out blow in Table IVa:
WO 92/21314 Pcr~us92~u4164 Table IVa esmaa~rss~~wmieras, ,~.~....~
=ngreaieat parts ...' ys ~s ~
Copolymer of EXAMPLE 1 w Water 30 H~ 20 (C H ) I~PF " 0.?
CPQ 0.25 HHT 0.10 K S O See Table IVb Several portions of a glass like the Control Glass of EXAMPLE I (but with a surface area of 3.3 m2/g) were slurry-treated with variQUS methanolie ascorbic acid solutions: The theoretical amounts of ascorbic acid on the treated glass are set out below in Table IVb.
Cements were formed by combining the treated glasses and liquids at a 1.4:1 powder: liquid ratio.
Dark set times were tested according to ISO standard DIS 991?, using a 400 g indenter. Approximately 30 seconds were required to xa~x the cement, transfer it t4 the mold specified,in the ISO standard, and place the mold in a 3?°C oven (also specified in the ISO
standard). ay then, some of the faster cements had already begun to set. These set times are indicated as "530" in Table IVb.
r ..i'.~.4~ : 6. .
-0 ' PT
S ' r . . . .. ._ ..", . ..., .,. . . ,, .. . . . r .. . . . .. 4 . . . n .. , . ... w _... ..... ._...~__._ ........... _.... .... ..... , .~ ~_. . ...~.<.
r.r....::.a.....a.,.;r>...~;r~~.r,.....,.... ... ...;,.. , . . ... ,., .. ....
, . .,. ..~ ..".. . . , WU 92/21314 ~GTlUS92/04164 Tahle~IVb =BO' BET Time~sea (dark) L
% 1C BZOe % Aacorbia Aaid on Gilass in L~quid o.os o.ia a.2~ o.s s,.o i.s ~.o 0.025 600 400 360 280 240 120 100 0.05 330 280 230 120 80 ?0 80 0.10 -_ 160 ?0 50 50 40 40 0.25 -_ 100 50 40 40 S30 530 0.5 _- _~- __ 40 35 35 35 1.0 __ _ __ 35 530 35 35 1.5 _-- __ --~ 530 530 X30 530 2.0 I _ __ ' ~'~ ~ 35 I S30 I 530 ~ 530 m~~ a~~ a The above data shows dark set times for cements ,.
containing varying amounts of reduc~.ng agent and oxidizing agent. The range of observed set times varied more than twenty_fold. Since the ISO test is performed at an elevated temgerature (3?°C)~, room temperature set times likely would be longer.
EBAM>'LE 5 Cements prspsrad from Liquids contaiaing o~cidiziag Ageat and =ahibitor The following liquid solutions were prepared:
WU 92/2!314 PCI'/US92/04164 ~~.~.o~J~
m~.s,i A v Par ts Ingrallient Doatrol Liquid Liquie! Liquid Liquid 2 8 Copolymer of 100 100 100 100 Water 60 60 60 60 CPQ 1.0 1.0 1.0 1.0 HHT 0.1 0.1 0.1 0.1 K S O 0.05 0.05 0.05 0.05 t 4-methoxyphenol - 0.1 0.5 1.0 ~.5 The untreated glass used in EXAMPLE 4 was slurry-treated by mixing together the ingredients set out below in Table VI. Each slurry was poured into a ..
plastic-lined tray, dried overnight at 45°C, and then sie~red through a ?4 ~cm mesh screen to make Glasses E, F
and G.
Tsbie va Parts ' =agredisat Glass E Glaas F ~ilsss ci methanol 40 40 40 glass powder 20 20 20 diphenyliodonium 0.40 0.40 0.40 chloride ascorbic acid , ~ 0.01 0.02 0.05, 3p Dark set times were determined using the method of EXAMPLE 4. The results are set out below in Table VII.
WO 92!21314 PCTlUS92l04164 2~.1~~~~ -24- , Tahle VI2 ;~- s~.~
nark get time, seoonds Glass E Glass'F Glass G
Control Liquid 2 330 280 230 Liquid B 870 840 510 Liquid C 930 840 810 Liquid D 900 870 810 The above data shows that adding 4-metho~cyphenol can to increase set times, thus providing some measure of control over polymerization.
E~pL1 6 cement prepa~rsa Osiag Thiourea as R.duaing Agent 20 Parts of the untreated glass of EXAMPLE 4 were slurr3.ed for 30 minutes in a solution of 0.15 parts thiourea in 40 parts methanol. The treated glass was dried overnight at 45°C and sieved through a 74 ~Cm mesh screen. A liquid solution was prepared from the ingredients set out below in Table VIII:
TahIA VIII
Ingrraieat Bans ~ --.-._,._ 50 ~
Copolymer of EXAMPLE 1 Water 30 ~ C H ~ - I+pF ' 1. 0 CpQ 0.25 BHT ' . 0.10 K S O 0.05 Cement mixes were prepared at a 1.4:1 powder:~liquid ratio, placed in the IS0 9917 mold described in EXAMPLE 4, and photocured from above for 60 seconds ewU ~~/2~ m a n~rius~z~om 6a _25_ ~1~.0~59 using a VISILUX 2 dental curing light. "Barcol"
hardness values were determined using a Barber-Colman hardness tester and indenter "G~lZJ935". The measured hardness values were 51 on the top and 4S on the bottom of the molded cement sample, indicating that very uniform cure was obtained.
EX~iMPLE 7 Dement prepar~d from a Liquid Dontaining 'Polys~arbo~cyl~irs l0 Acid pithout Pendant Htbylania t~nsaturation A liquid salution containing a separate ethylenically-unsaturated ingredient was prepared by mixing together the ingredients set out below in Table IX:
Table I~
=ngrediant Barts~
L
33% solution of polyacrylic 6 acid ( ~25,OOOa in water 2 0 IiEMA 4 UDMAl 0 . 3 GDMAZ 0.3 Trimethylhexamethylene diisocyanate end-capped at a 2:1 molar retie with HEMA
Glyceryl dimethacrylate A mixture of 0.g parts Glass H and 0.8 parts Glass C
was hand-spatulated with l part of the liquid. Using the method of EXAMPLE 2,, a dark set time of 10 minutes, 10 seco~ids was observed.~t The average of the top and bottom Barcol hardness values after 1 hour was 43.
A control cement was prepared by mixing 1.6 parts of the untreated Control Glass with 1 part of the liquid. A dark yet time of 50 minutes was observed.
The average of the top and bottom Barcol hardness values after 1 hour was only 9.
u,.,; . ; : . ", . ,. ,.,., .., wc~ ~ziz~3~4 r~criU~h2~oa~6a EXI~P~E 8 Mi~cture of Commercial Cement Liquid with powder Containing oxidizing Agent and Reducing Agent 1 Part "GC Fuji LC" Liquid (the liquid portion of a commercial light-curable glass ionamer cement from GC Corp.) was hand-spatulated with 1.4 parts Glass 1~ (which was made by combining 0.7 parts of the potassium persulfate-treated Glass B and 0.7 parts of the ascorbic acid-treated Glass C). Using the method of EXAMPLE 7, a dark set time of 10 minutes and an average Barcol harness after 2 hours of 72 were observed.
A control cement was prepared by hand-spatulating 1 part GC Fuji LC Liquid with the untreated Control Glass and stored under a yellow safelight.
After ~. hour and 45 minutes, the mixture had not set.
This example demonstrates that a commercial light-curable glass ionomer cement can readily be modified to improve its dark set time.
Microenaapsulation of Kx8208 in Cellulose Aoetate Butyrate (CAB) 8.0 Parts CAB containing 18% butyl groups ' were dissolved in 800 parts methylene chloride.
Separately, 5.0 parts KaSxOg were dissolved in 200 parts water. 330 Parts of the methylene chloride solution were transferred to a stainless steel vessel suspended in a room temperature water bath. A stirring impeller was suspended in the vessel and spun at 700 rpm. To .
the stirred solution was added 50 parts of the KZS2Og solution. The temperature of the water bath was raised to 37-38°C, thereby slowly evaporating the methylene chloride. After one-half hour, ice was added to the water bath to lower the temperature to 24°C. 165 Parts n-hexane were added slowly to the vessel in order to precipitate the encapsulated oxidizing agent. The ~2,/w precipitate was filtered, washed with cold n-hexane and dried under vacuum. The resulting dry microcapsules were deagglomerated in an electric coffee grinder, yielding a very light fluffy powder.
E,PLE
Fonder Containing Microenaapgulated oxidizing Agent and Unenaapaulat~d Reducing Agent 67 Parts of the untreated glass used in EXAMPLE 4 were mixed on a roll mill for 2 hour with 0.232 parts of the microcapsules of EXAMPLE 9. 20 Farts of the resulting treated glass were mixed on a ..,.~
roll mill for ane-half hour with 20 parts of a fresh sample of Glass C. The resulting mixture was labelled "Glass H". 2t was combined at a 1.4:1 powder: liquid ratio with Control Liquid 3 (a liquid like the Control Liquid of EXAMPLE 1, but containing 1 part rather than 0.7 parts (C6H5)2I*PF6 ) and evaluated using the method of EXAMPLE 2. A set time of 12.5 minutes was observed.
Portions of Glass H were subjected to accelerated aging for 4 days and 8 days at 45°C. Set time measurements showed that the dark curing reaction was not slowed, thus indicating that the microcapsules had excellent storage stability.
EBAMPTrE 11 Miaroencapaulation of Ascorbic Acid in CAB
3 Parts ascorbic acid were dissolved in 60 parts water. 8 Parts CAB,were dissolved in 800 parts dichloromethane. 330 Parts of the CAB solution and 5.0 parts c~f the ascorbic~~acid solution were added to a' stainless steel vessel and stirred at 708 rpm. A
38-40°C water bath was placed under the vessel. 165 Parts n-hexane were added slowly to the stirred mixture 35. over a one-half hour period. A granular precipitate formed. stirring was continued for 15 additional minutes. The warm water bath was replaced with an 'WO 92/Z 1314 PCT/ US~12104164 -zs~-ice~water bath, resulting in the formation of additional precipitate. The~precipitate was ffiltered, washed with n-hexane and dried under vacuum. The dried product was ground to a fine powder.
EBJ'~MPLB ~.2 8ila~aol-°~reated t~la~es Ponder Cont~aiu~.ng Mir~roenoapsulrated ~cx~~t~g, and as~~rb~,c~ Aaid 4 Parts "A-174" gamma~methacryloxypropy~.
trimethoxysilane (Union Carbide Carp.), 25 parts methanol, and 25 parts water were mixed, then acidified with trifluoroacetic acid until the pH reached 3.9.
The mixture was stirred for 25 minutes at roam temperature, yielding a silanol,--contafining treating solution. 1,00 Parts of a glass like the Control Glass of EXAMPLE 1 (but having a surface area of 2.8 M2/g rather than 2.6 M2/q) were combined with the silanal treating solution, slurried for 1.5 hours at room temperature, dried overnight at 45°C, and sieved through a 74 ~m mesh screen. A portion of the treated powder (5 parts] was mixed with 0.012 parts of 'the microencapsulated potassium persulfate of EXAMPLE 9.
Another portion of the treated powder (5 parts) was mixed with 0.06 parts of the microencapsulated ascorbio acid of EXAMPLE 11. The two powder portions were combined and then r~11-m3.lled for one-half hour. The resulting blended powder was combined at a 2.2:1 powder: liquid ratio with Control Liquid ~ (a liquid like Control Liquid 3, but containing 0.05 parts BHT
rather than 0.1 parts). The resulting cured cement was evaluated fgr CS and I7TS using the method of EXAMPLE 1 (but with a 60 second photocure rather than 80 seconds). The respectfive CS and DTS values were 195 MPa and 38 MPa. Lf photocuring was omitted, the respectfive CS and DTS values were 180 MFa and z5 MPa.
Adhesion to enamel was evaluated by generally following the procedure of EXAMPLE 2. However, the WU '~~1Z1314 PC1'/US92/04164 21~.~~~9 potted teeth were ground to expose only the enamel surface. The polished enamel surface was etched far 15 seconds using gelled 37% phosphoric acid, washed far 30 seconds with water and then dried using compressed air.
The measured adhesion to etched enamel was ~.8 MPa.
EXAMPLE ~,3 Miaroencapsula~tion by x~reaipitative Method The three separate solutions whose compositions are set out below in Table X ware each placed in separate addition funnels:
~~~~~ g Run ~to. Solution 1 3 parts ascorbic acid in 60 parts water 2 3 parts K S O in 60 parts water 3 3 parts (NH y S O in 60 parts water Tn a series of three separate runs, 50 parts of one of the solutions shown above were added to 366 parts of a stirred 1% solution of CRB in ethyl acetate contained in a stainless steel vessel immersed in a 4°C water bath. The stirrer speed Haas maintained at 700 rpm and the bath temperature was maintained at 4°C. 267 Parts of ice cold n-hexane were added dropwise to the stirred solution over a 30 minute period. Granular spherical microcapsules were formed, as evidenced by microscopic examination: Stirring was continued for an additional 15-minutes: The granular~precipitate was filtered,;
washed with ice-cold n-hexane, dried under vacuum and then deagglomereted in ;an electric coffee mill.
WCl X2121314 PCI'lUS92/04164 ~30~
EXAMPLE ~.4 Preparation of Tri-Cure Cement from 8ilanol~~Treated ~3laes Powder To 100 parts of a silanol~treated glass like that of EXAMPLE 12 were added 0.55 parts of the ascorbic acid microcapsules of Run no. 1 of EXAMPLE 13, and 0.i parts of the K2S20g microcapsules of Run no. 2 of EXAMPLE 13. The mixture was mixed on a roll mill for 1 hour. Using the method of EXAMPLE 4, the dark l0 set time was determined to be 4 minutes, 20 seconds.
Using the method of EXAMPLE 12, the respective CS and DTS values after light-curing were determined to be 210 MPa and 31 MPa.
EB~1MPLE Z 5 preparation of Tri-Cure Cement from Miaroenaapeulated (NH4~aSZ~8 and Asoorbia Aaid A solution of 2 parts A1?4 silane, 12.5 parts methanol, 12.5 parts water and 0.22 parts acetic acid was stirred for 30 minutes, combined with 50 parts of the untreated glass of EXAMPLE 12, slurried for 1.5 hours at room temperature, dried overnight-at 45°C, and sieved through a ?4 hem mesh screen.
20 Parts of the resultant powder were added to 0.11 parts'of ,the microencapsulated ascorbic acid of Run no. 1 of EXAMPLE 13 and 0.02 parts of the microencapsulated ammonium persulfate of Run no. 3 of EXAMPLE 13. The powders were mixed by roll.-milling for about 1 hour. When evaluated as in EXAMPLE 14, the dark set time was determined to be 4 minutes, 20 seconds, and the CS and DTS values were 'determined to be 20S MPa and 30 MPa.
Modification of Commercial Cements In a first run, 4.5 parts "GC Fuji LC" light-curable glass ionomer cement were combined with 0.025 WO 92/21314 ~ ~ ~ ~ ~ ~ PC'1'/US92/04164 _31_ parts of the ascorbic acid microcapsules of Run no. 1 of EXAMPLE 13 and 0.0045 parts of thd potassium persulfate microcapsules of Run no. 2 of EXAMPLE 13.
The resulting powder mixture was roll-milled for one half hour. The powder was labeled "Modified GC Glass".
As a second run, 4.1 parts "Kerr XR" ionomer powder (Kerr Division of Sybron, Inc.) were combined with 0.0336 parts of the ascorbic acid microcapsules and 0.0044 parts of the potassium persulfate l0 microcapsules. After roll-milling, the resulting powder was labelled "Modified Kerr Glass".
The modified glasses and the unmodified commercial glasses were independently combined at a 1.4:1 powder: liquid ratio with the corresponding commercial liquids supplied by the manufacturers, and permitted to harden without photocuring. The resulting cements were evaluated for room temperature and ISO
dark set time using the methods of EXAMPLES 2 and 4:
The cements were also evaluated for Barcol hardness using the method of EXAMPLE 6. Set out below in Tables XIa and XIb are the set time and Barcol hardness ~ralues for each cement.
Table XIa ac cement 0n~nodified Modiffea Dark Set Tiale' Room Temperature 35 min 12 min 30 sec ISO (37C) 8 min 40 sec 5 min 20 sec Harcol Hardae8s ~ . ~. . ' ~ r Room'Temperature .. 30 After 15 minutes 0 23 After one hour 15 47 ISO (37C) After 15 minutes 22 22 After one hour 34 54 WU 92/21314 PGfi/US92/041G4 _3Z_ Table alb Kerr cement Onmodified Modified Dark Sot Timo Room Temperature 35 min 12 min 30 sec ISO (37C) ~ 14 min 5 min ~o sec Haraol 8ardn~ss Room Temperature After 15 minutes 0 0 After one hour 0 24 ISO (37C) After l5 minutes 0 0 After one hour ~ 8 f 34 As the above data illustrates, under dark conditions the modified cements set more rapidly and reached a higher ultimate hardness than the unmodified cements.
The modified cements would therefore be much better suited to deep cure restorations, cure without a light or with a faulty light, and other low light situations.
Although this invention has been described ' using certain illustrative examples, it should -be understood that the invention is not limited to the specific exemplary embodiments shown in this specif ication:
__. ..~...... .... .. r... ...... .. . ..., , ,. .. F~... a.. ., , .... ,f..:~
. . ;:.~,. . ,. . . .,
Claims (23)
1. A water-containing, ionically-hardenable, photocurable, ethylenically-unsaturated dental cement, comprising a) finely-divided acid-reactive filler, b) water-miscible acidic polymer, c) photoinitiator, d) water-soluble reducing agent, and e) water-soluble oxidizing agent.
2. A cement according to claim 1, wherein the filler comprises metal oxide, metal salt or glass.
3. A cement according to claim 2, wherein the glass comprises fluoroaluminosilicate glass.
4. A cement according to claim 1, 2 or 3, wherein the polymer comprises a homopolymer or copolymer of an alkenoic acid.
5. A cement according to claim 4, wherein the polymer comprises a copolymer of acrylic acid containing one or more ethylenically-unsaturated groups.
6. A cement according to any one of claims 1 to 5, containing as a further component an ethylenically-unsaturated monomer.
7. A cement according to any one of claims 1 to 6, wherein the reducing agent and the oxidizing agent are capable of initiating gelation of a 10:10:1 weight basis water:acrylamide:methylene bis-acrylamide mixture.
8. A cement according to any one of claims 1 to 7, wherein the reducing agent is selected from the group consisting of ascorbic acid, cobalt (II) chloride, ferrous chloride, ferrous sulfate, hydrazine, oxalic acid, thiourea, and salts of a dithionite or sulfite anion.
9. A cement according to any one of claim 1 to 7, wherein the reducing agent comprises ascorbic acid or thiourea.
10. A cement according to any one of claims 1 to 9, wherein the oxidizing agent is selected from the group consisting of cobalt (III) chloride, tert-butyl hydroperoxide, ferric chloride, perboric acid and its salts, and salts of a permanganate or persulfate anion.
11. A cement according to any one of claims 1 to 9, wherein the oxidizing agent comprises potassium or ammonium persulfate.
12. A cement according to any one of claims 1 to 11, wherein the cement has two parts respectively containing glass and polymer, and one agent is packaged with the glass and the other agent is packaged with the polymer.
13. A cement according to any one of claims 1 to 12, wherein at least one of the agents is microencapsulated.
14. A cement according to claim 13, wherein the cement has two parts respectively containing glass and polymer, and both agents are packaged with the glass.
15. A cement according to claim 13, wherein the cement has two parts respectively containing glass and polymer, and both agents are packaged with the polymer.
16. A cement according to claim 13, wherein at least one of the agents is microencapsulated with water-soluble encapsulant.
17. A cement according to claim 13, wherein at least one of the agents is microencapsulated with water-insoluble encapsulant.
18. A cement according to claim 17, wherein the encapsulant comprises cellulose acetate butyrate.
19. A cement according to any one of claims 1 to 18, wherein the cement contains about 3% to about 25% water, about 25% to about 85% filler, about 10% to about 50%
polymer, about 0.1% to about 5% photoinitiator, about 0.02%
to about 5% reducing agent, and about 0.02% to about 5%
oxidizing agent.
polymer, about 0.1% to about 5% photoinitiator, about 0.02%
to about 5% reducing agent, and about 0.02% to about 5%
oxidizing agent.
20. A cement according to claim 19, wherein the cement contains about 5% to about 20% water, about 50% to about 75%
filler and about 10% to about 30% polymer.
filler and about 10% to about 30% polymer.
21. A dental cement powder, comprising finely-divided acid-reactive filler, water-soluble reducing agent and water-soluble oxidizing agent, at least one of the agents being microencapsulated.
22. A dental cement liquid, comprising water-miscible acidic polymer, water-soluble reducing agent and water-soluble oxidizing agent, at least one of the agents being microencapsulated.
23. A liquid according to claim 22, further comprising an ethylenically-unsaturatd moiety.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/708,988 | 1991-05-31 | ||
US07/708,988 US5154762A (en) | 1991-05-31 | 1991-05-31 | Universal water-based medical and dental cement |
PCT/US1992/004164 WO1992021314A1 (en) | 1991-05-31 | 1992-05-19 | Universal water-based medical and dental cement |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2110259A1 CA2110259A1 (en) | 1992-12-10 |
CA2110259C true CA2110259C (en) | 2004-01-27 |
Family
ID=24848015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002110259A Expired - Fee Related CA2110259C (en) | 1991-05-31 | 1992-05-19 | Universal water-based medical and dental cement |
Country Status (15)
Country | Link |
---|---|
US (1) | US5154762A (en) |
EP (1) | EP0588878B2 (en) |
JP (1) | JP3288698B2 (en) |
KR (1) | KR100245578B1 (en) |
AU (2) | AU2009292A (en) |
BR (1) | BR9206071A (en) |
CA (1) | CA2110259C (en) |
DE (1) | DE69214287T2 (en) |
DK (1) | DK0588878T3 (en) |
ES (1) | ES2092118T3 (en) |
HK (1) | HK1007687A1 (en) |
MX (1) | MX9202548A (en) |
NO (1) | NO303524B1 (en) |
WO (1) | WO1992021314A1 (en) |
ZA (1) | ZA923812B (en) |
Families Citing this family (242)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1323949C (en) * | 1987-04-02 | 1993-11-02 | Michael C. Palazzotto | Ternary photoinitiator system for addition polymerization |
AU3326193A (en) * | 1991-12-31 | 1993-07-28 | Minnesota Mining And Manufacturing Company | Water-based amalgam adhesive |
US5710194A (en) * | 1993-04-19 | 1998-01-20 | Dentsply Research & Development Corp. | Dental compounds, compositions, products and methods |
US6391940B1 (en) | 1993-04-19 | 2002-05-21 | Dentsply Research & Development Corp. | Method and composition for adhering to metal dental structure |
US5338773A (en) * | 1993-04-19 | 1994-08-16 | Dentsply Research & Development Corp. | Dental composition and method |
US6500879B1 (en) * | 1993-04-19 | 2002-12-31 | Dentsply Research & Development Corp. | Dental composition and method |
US5530038A (en) * | 1993-08-02 | 1996-06-25 | Sun Medical Co., Ltd. | Primer composition and curable composition |
US5888491A (en) * | 1993-12-06 | 1999-03-30 | Minnesota Mining And Manufacturing Company | Optionally crosslinkable coatings, compositions and methods of use |
US6312668B2 (en) | 1993-12-06 | 2001-11-06 | 3M Innovative Properties Company | Optionally crosslinkable coatings, compositions and methods of use |
US5501727A (en) * | 1994-02-28 | 1996-03-26 | Minnesota Mining And Manufacturing Company | Color stability of dental compositions containing metal complexed ascorbic acid |
WO1995022956A1 (en) * | 1994-02-28 | 1995-08-31 | Minnesota Mining And Manufacturing Company | Paste:paste glass ionomer cement system and methods |
FR2722504B1 (en) * | 1994-07-13 | 1999-07-23 | Gti Process Sa | PROCESS FOR THE AGGREGATION OF A PULVERULENT OR PARTICULATE MATERIAL FOR THE CONSTITUTION OF A COMPOSITE SOLID MATERIAL |
US5607663A (en) * | 1994-12-01 | 1997-03-04 | Minnesota Mining And Manufacturing Company | Hydrocarbyl containing coatings, compositions and methods of use |
US5662887A (en) * | 1994-12-01 | 1997-09-02 | Minnesota Mining And Manufacturing Company | Fluorocarbon containing coatings, compositions and methods of use |
DE4445266A1 (en) * | 1994-12-19 | 1996-06-20 | Thera Ges Fuer Patente | Fluoride-releasing composite materials |
US5534562A (en) * | 1995-04-07 | 1996-07-09 | Ultradent Products, Inc. | Compositions and methods for priming and sealing dental and biological substrates |
JP4002996B2 (en) * | 1995-06-15 | 2007-11-07 | スリーエム カンパニー | Method for attaching temporary denture apparatus using glass ionomer cement and kit therefor |
US6391286B1 (en) | 1995-11-17 | 2002-05-21 | 3M Innovative Properties Company | Use of metallofluorocomplexes for dental compositions |
US6050815A (en) * | 1996-03-15 | 2000-04-18 | 3M Innovative Properties Company | Precoated dental cement |
US6136885A (en) * | 1996-06-14 | 2000-10-24 | 3M Innovative Proprerties Company | Glass ionomer cement |
US5814682A (en) * | 1996-06-14 | 1998-09-29 | Rusin; Richard P. | Method of luting a provisional prosthetic device using a glass ionomer cement system and kit therefor |
JPH1036116A (en) * | 1996-07-25 | 1998-02-10 | Kuraray Co Ltd | Metal fluoride and dental composition containing the metal fluoride |
US7332537B2 (en) | 1996-09-04 | 2008-02-19 | Z Corporation | Three dimensional printing material system and method |
US5973022A (en) * | 1996-11-01 | 1999-10-26 | Dentsply Research & Development Corp. | Dental composition system and method |
US6387980B2 (en) | 1996-11-01 | 2002-05-14 | Dentsply Research & Development Corp. | Dental composition system and method |
US5922786A (en) * | 1997-04-11 | 1999-07-13 | Minnesota Mining And Manufacturing Company | Dental primer composition |
US5861445A (en) * | 1997-05-08 | 1999-01-19 | American Dental Association Health Foundation | Reinforcement of dental and other composite materials |
DE69817760T2 (en) * | 1997-06-09 | 2004-08-05 | KURARAY CO., LTD, Kurashiki | POLYMERIZABLE COMPOSITION FOR DENTAL APPLICATIONS |
US5859089A (en) * | 1997-07-01 | 1999-01-12 | The Kerr Corporation | Dental restorative compositions |
US6506816B1 (en) | 1997-07-17 | 2003-01-14 | 3M Innovative Properties Company | Dental resin cements having improved handling properties |
US5913840A (en) * | 1997-08-15 | 1999-06-22 | Minnesota Mining And Manufacturing Company | Soft orthopedic casting article with reinforcement system |
JPH11209214A (en) * | 1998-01-16 | 1999-08-03 | Gc Corp | Dental repairing material |
DE19802644B4 (en) * | 1998-01-24 | 2010-03-18 | Voco Gmbh | Process for the preparation of dental, aqueous cement mixtures |
EP0948956A3 (en) * | 1998-03-27 | 2000-07-19 | DENTSPLY DETREY GmbH | Self-curing dental adhesive |
DE19818210C5 (en) * | 1998-04-24 | 2007-02-08 | Ivoclar Vivadent Ag | Radically polymerizable dental material |
US5971754A (en) * | 1998-07-30 | 1999-10-26 | Sondhi; Anoop | Indirect bonding method and adhesive for orthodontic treatment |
DE19846673A1 (en) * | 1998-10-09 | 2000-04-20 | Siemens Ag | Stack manipulation activity prevention procedure for intelligent chip-card integrated circuits (ICs) |
US6334775B2 (en) | 1999-02-16 | 2002-01-01 | American Dental Association Health Foundation | Continuous fiber-reinforced dental restorations |
US6979702B1 (en) | 1999-03-17 | 2005-12-27 | The Regents Of The University Of Michigan | Ionomer composite compositions |
JP4636656B2 (en) | 1999-07-08 | 2011-02-23 | 株式会社松風 | Dental adhesive composition |
WO2001034371A2 (en) | 1999-11-05 | 2001-05-17 | Z Corporation | Material systems and methods of three-dimensional printing |
US6306206B1 (en) | 2000-01-06 | 2001-10-23 | Ultradent Products, Inc. | Temporary dental cement compositions and related methods and systems |
US20010050031A1 (en) | 2000-04-14 | 2001-12-13 | Z Corporation | Compositions for three-dimensional printing of solid objects |
CN1189159C (en) | 2000-05-05 | 2005-02-16 | 欧莱雅 | Micro-capsule contg. water soluble beauty-care activity component water nuclear, and composition contg. same |
US20030069327A1 (en) | 2001-08-09 | 2003-04-10 | Uwe Walz | Dental compostions comprising bisacrylamides and use thereof |
US6734223B2 (en) | 2000-08-11 | 2004-05-11 | Dentsply Detrey Gmbh | Polyaminoester and their application in dental compositions |
CA2417203A1 (en) * | 2000-08-11 | 2002-02-21 | Dentsply International, Inc. | Dental compositions comprising bisacrylamides and use thereof |
EP1413283B1 (en) * | 2000-08-11 | 2017-09-20 | DENTSPLY International Inc. | Dental compositions comprising bisacrylamides and use thereof |
US6612769B2 (en) | 2000-12-13 | 2003-09-02 | Innovative Properties Company | Package and dispensing actuator for multiple-component compositions |
KR100394361B1 (en) * | 2000-12-18 | 2003-08-09 | 김대현 | Laminated paste dental crown for and preparation method thereof |
US6613812B2 (en) * | 2001-01-03 | 2003-09-02 | 3M Innovative Properties Company | Dental material including fatty acid, dimer thereof, or trimer thereof |
DE10101523B4 (en) * | 2001-01-15 | 2012-07-19 | Ivoclar Vivadent Ag | Dental materials based on polyfunctional amides |
US6953832B2 (en) * | 2001-01-15 | 2005-10-11 | Ivoclar Vivadent Ag | Dental materials based on polyfunctional amides |
US6818682B2 (en) | 2001-04-20 | 2004-11-16 | 3M Innovative Properties Co | Multi-part dental compositions and kits |
DE10124029B4 (en) * | 2001-05-16 | 2004-08-26 | 3M Espe Ag | Initiator system for acidic dental formulations |
DE10124028B4 (en) * | 2001-05-16 | 2010-02-18 | 3M Espe Ag | Self-adhesive dental materials |
US6765038B2 (en) | 2001-07-27 | 2004-07-20 | 3M Innovative Properties Company | Glass ionomer cement |
JP2003105008A (en) * | 2001-09-28 | 2003-04-09 | Gc Corp | Paste-like polymerizable composition |
US7173074B2 (en) * | 2001-12-29 | 2007-02-06 | 3M Innovative Properties Company | Composition containing a polymerizable reducing agent, kit, and method |
JP4629339B2 (en) * | 2001-12-29 | 2011-02-09 | スリーエム イノベイティブ プロパティズ カンパニー | Compositions, kits and methods containing polymerizable reducing agents |
WO2003061606A1 (en) * | 2002-01-23 | 2003-07-31 | Uab Research Foundation | Glass-ionomer cements containing amino acids |
US6756417B2 (en) * | 2002-03-13 | 2004-06-29 | Ultradent Products, Inc. | Dental bonding compositions for adhering amalgam restoratives to dental substrates |
US6729879B2 (en) | 2002-03-13 | 2004-05-04 | Ultradent Products, Inc. | Dental bonding methods for adhering amalgam restoratives to dental substrates |
US6982288B2 (en) * | 2002-04-12 | 2006-01-03 | 3M Innovative Properties Company | Medical compositions containing an ionic salt, kits, and methods |
US20050203217A1 (en) * | 2002-04-30 | 2005-09-15 | Pomrink Gregory J. | Stabilizers for polymerizable biocompatible materials |
US6767955B2 (en) * | 2002-05-08 | 2004-07-27 | Pentron Clinical Technologies | Flowable dental resin materials and method of use thereof |
US6924325B2 (en) * | 2002-06-21 | 2005-08-02 | Kerr Corporation | Silver-containing dental composition |
JP4485117B2 (en) * | 2002-06-27 | 2010-06-16 | 日東電工株式会社 | Protective peeling film |
US7134875B2 (en) * | 2002-06-28 | 2006-11-14 | 3M Innovative Properties Company | Processes for forming dental materials and device |
US6773261B2 (en) * | 2002-06-28 | 2004-08-10 | 3M Innovative Properties Company | Processes for forming dental materials |
US7091259B2 (en) * | 2002-07-03 | 2006-08-15 | 3M Innovative Properties Company | Dental fillers, pastes, and compositions prepared therefrom |
US20040038009A1 (en) * | 2002-08-21 | 2004-02-26 | Leyden Richard Noel | Water-based material systems and methods for 3D printing |
DE10241434B4 (en) * | 2002-09-06 | 2007-09-13 | Ivoclar Vivadent Ag | Dental polymer film |
US7087109B2 (en) * | 2002-09-25 | 2006-08-08 | Z Corporation | Three dimensional printing material system and method |
DE10261241A1 (en) * | 2002-12-20 | 2004-07-15 | 3M Espe Ag | Dental material with bacteriostatic and / or bactericidal substances |
US20040120901A1 (en) * | 2002-12-20 | 2004-06-24 | Dong Wu | Dental compositions including enzymes and methods |
US20040122126A1 (en) * | 2002-12-20 | 2004-06-24 | Dong Wu | Free-radical initiator systems containing enzymes, compositions, and methods |
US20040206932A1 (en) | 2002-12-30 | 2004-10-21 | Abuelyaman Ahmed S. | Compositions including polymerizable bisphosphonic acids and methods |
US20040185013A1 (en) * | 2003-01-30 | 2004-09-23 | Burgio Paul A. | Dental whitening compositions and methods |
US7223826B2 (en) * | 2003-01-30 | 2007-05-29 | 3M Innovative Properties Company | Amide-functional polymers, compositions, and methods |
US20040151691A1 (en) * | 2003-01-30 | 2004-08-05 | Oxman Joel D. | Hardenable thermally responsive compositions |
US7166651B2 (en) * | 2003-05-19 | 2007-01-23 | Kerr Corporation | Two-part self-adhering dental compositions |
EP2269808B1 (en) | 2003-05-21 | 2017-03-22 | 3D Systems Incorporated | Thermoplastic powder material system for appearance models from 3D printing systems |
US7214726B2 (en) * | 2003-07-17 | 2007-05-08 | Kerr Corporation | Methods of using two-part self-adhering dental compositions |
EP1653913B1 (en) * | 2003-08-12 | 2012-05-23 | 3M Innovative Properties Company | Self-etching dental compositions and methods |
US20050059757A1 (en) * | 2003-08-29 | 2005-03-17 | Z Corporation | Absorbent fillers for three-dimensional printing |
US7250452B2 (en) * | 2003-09-26 | 2007-07-31 | 3M Innovative Properties Company | Dental compositions and methods with arylsulfinate salts |
US7030169B2 (en) * | 2003-09-26 | 2006-04-18 | 3M Innovative Properties Company | Arylsulfinate salts in initiator systems for polymeric reactions |
US7064152B2 (en) * | 2003-09-26 | 2006-06-20 | 3M Innovative Properties Company | Arylsulfinate salts in photoinitiator systems for polymerization reactions |
US7026367B2 (en) * | 2003-09-26 | 2006-04-11 | 3M Innovative Properties Company | Photoiniators having triarylsulfonium and arylsulfinate ions |
WO2005072683A1 (en) * | 2004-01-21 | 2005-08-11 | 3M Innovative Properties Company | Dental compositions and kits containing bitterness inhibitors, and related methods |
JP2005289961A (en) * | 2004-03-12 | 2005-10-20 | Shiyoufuu:Kk | Microcapsule-containing curable composition |
US7649029B2 (en) * | 2004-05-17 | 2010-01-19 | 3M Innovative Properties Company | Dental compositions containing nanozirconia fillers |
US7090722B2 (en) | 2004-05-17 | 2006-08-15 | 3M Innovative Properties Company | Acid-reactive dental fillers, compositions, and methods |
US7090721B2 (en) * | 2004-05-17 | 2006-08-15 | 3M Innovative Properties Company | Use of nanoparticles to adjust refractive index of dental compositions |
US7156911B2 (en) * | 2004-05-17 | 2007-01-02 | 3M Innovative Properties Company | Dental compositions containing nanofillers and related methods |
JP5214242B2 (en) | 2004-07-08 | 2013-06-19 | スリーエム イノベイティブ プロパティズ カンパニー | Dental methods, compositions, and kits containing acid-sensitive dyes |
EP1634561A1 (en) * | 2004-08-06 | 2006-03-15 | DENTSPLY DETREY GmbH | Reactive filler for dental cements |
AU2005272808B8 (en) | 2004-08-11 | 2011-11-03 | 3M Deutschland Gmbh | Self-adhesive compositions including a plurality of acidic compounds |
ATE526935T1 (en) | 2004-11-16 | 2011-10-15 | 3M Innovative Properties Co | DENTAL COMPOSITIONS CONTAINING CALCIUM PHOSPHORUS RELEASING GLASS |
KR101240883B1 (en) | 2004-11-16 | 2013-03-07 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | Dental fillers, methods, compositions including a caseinate |
CN101115459B (en) | 2004-11-16 | 2012-03-21 | 3M创新有限公司 | Dental fillers including a phosphorus containing surface treatment |
WO2006055327A1 (en) | 2004-11-16 | 2006-05-26 | 3M Innovative Properties Company | Dental fillers and compositions including phosphate salts |
US20060204452A1 (en) * | 2005-03-10 | 2006-09-14 | Velamakanni Bhaskar V | Antimicrobial film-forming dental compositions and methods |
US20060205838A1 (en) * | 2005-03-10 | 2006-09-14 | Velamakanni Bhaskar V | Hardenable antimicrobial dental compositions and methods |
JP4794201B2 (en) | 2005-04-25 | 2011-10-19 | 株式会社松風 | 2 paste type glass ionomer cement |
AU2006244182B2 (en) | 2005-05-09 | 2012-02-02 | 3M Innovative Properties Company | Dental compositions containing hybrid monomers |
ATE473723T1 (en) * | 2005-08-05 | 2010-07-15 | 3M Espe Ag | DENTAL COMPOSITIONS CONTAINING A SURFACE-MODIFIED FILLER |
US20080041520A1 (en) * | 2006-08-18 | 2008-02-21 | Dentsply Research And Development Corp. | Adhesive and method for binding artificial plastic teeth |
US20070054978A1 (en) * | 2005-09-07 | 2007-03-08 | Kabushiki Kaisha Shofu | One-liquid medical and dental curable composition |
US7495054B2 (en) * | 2005-09-19 | 2009-02-24 | 3M Innovative Properties Company | Curable compositions containing dithiane monomers |
EP1787627A1 (en) * | 2005-11-17 | 2007-05-23 | 3M Innovative Properties Company | Anti-microbial dental impression material |
US8026296B2 (en) | 2005-12-20 | 2011-09-27 | 3M Innovative Properties Company | Dental compositions including a thermally labile component, and the use thereof |
US7896650B2 (en) | 2005-12-20 | 2011-03-01 | 3M Innovative Properties Company | Dental compositions including radiation-to-heat converters, and the use thereof |
US7776940B2 (en) | 2005-12-20 | 2010-08-17 | 3M Innovative Properties Company | Methods for reducing bond strengths, dental compositions, and the use thereof |
EP1968528B1 (en) * | 2005-12-29 | 2016-02-17 | 3M Innovative Properties Company | Dental compositions with surface-treated filler for shelf stability |
EP1968525B1 (en) * | 2005-12-29 | 2016-07-20 | 3M Innovative Properties Company | Dental compositions and initiator systems with polycyclic aromatic component |
AU2006332731A1 (en) * | 2005-12-29 | 2007-07-12 | 3M Innovative Properties Company | Dental compositions with a water scavenger |
US20080299520A1 (en) * | 2005-12-29 | 2008-12-04 | Ali Mahfuza B | Foamable Dental Compositions and Methods |
DE102006010075B4 (en) * | 2006-03-04 | 2010-01-28 | Ivoclar Vivadent Ag | Process for the production of plastic moldings that can be used in the dental field |
ATE477283T1 (en) | 2006-05-31 | 2010-08-15 | 3M Innovative Properties Co | POLYMERIZABLE COMPOSITIONS CONTAINING SALTS OF BARBITURIC ACID DERIVATIVES |
EP2377507B1 (en) | 2006-09-13 | 2013-04-24 | 3M Innovative Properties Company | Dental compositions including organogelators, products, and methods |
US20080096150A1 (en) | 2006-10-23 | 2008-04-24 | 3M Innovative Properties Company | Dental articles, methods, and kits including a compressible material |
US9539065B2 (en) | 2006-10-23 | 2017-01-10 | 3M Innovative Properties Company | Assemblies, methods, and kits including a compressible material |
DE102006050153A1 (en) | 2006-10-25 | 2008-05-08 | Ivoclar Vivadent Ag | Microencapsulated photoinitiators and their use for dental materials |
EP2079246A4 (en) * | 2006-11-01 | 2012-08-22 | Fujitsu Ltd | Wireless communication apparatus and wireless communication method |
EP2089215B1 (en) | 2006-12-08 | 2015-02-18 | 3D Systems Incorporated | Three dimensional printing material system |
US9943465B2 (en) | 2006-12-13 | 2018-04-17 | 3M Innovative Properties Company | Methods of using a dental composition having an acidic component and a photobleachable dye |
US8263681B2 (en) * | 2006-12-28 | 2012-09-11 | 3M Innovative Properties Company | Dental compositions with natural tooth fluorescence |
WO2008083275A2 (en) | 2006-12-28 | 2008-07-10 | 3M Innovative Properties Company | Dental filler and methods |
EP2109436B1 (en) * | 2006-12-28 | 2012-01-25 | 3M Innovative Properties Company | Adhesive composition for hard tissue |
US20100021869A1 (en) * | 2006-12-28 | 2010-01-28 | Abuelyaman Ahmed S | (meth)acryloyl-containing materials, compositions, and methods |
JP5129267B2 (en) | 2007-01-10 | 2013-01-30 | スリーディー システムズ インコーポレーテッド | 3D printing material system with improved color, article performance and ease of use |
WO2008103450A2 (en) | 2007-02-22 | 2008-08-28 | Z Corporation | Three dimensional printing material system and method using plasticizer-assisted sintering |
US8568649B1 (en) * | 2007-03-20 | 2013-10-29 | Bowling Green State University | Three-dimensional printer, ceramic article and method of manufacture |
US8475946B1 (en) | 2007-03-20 | 2013-07-02 | Bowling Green State University | Ceramic article and method of manufacture |
WO2008134024A2 (en) * | 2007-04-25 | 2008-11-06 | Dentsply International Inc. | Self-adhesive dental cement |
US8735463B2 (en) * | 2007-05-31 | 2014-05-27 | Creighton University | Self-healing dental composites and related methods |
US20110229838A1 (en) * | 2007-10-01 | 2011-09-22 | Kalgutkar Rajdeep S | Orthodontic composition with polymeric fillers |
DE102007050768A1 (en) * | 2007-10-22 | 2009-04-23 | Heraeus Medical Gmbh | Polymethylmethacrylate bone cement |
JP5461415B2 (en) * | 2007-11-01 | 2014-04-02 | スリーエム イノベイティブ プロパティズ カンパニー | Dental composition and initiator system with color stable amine electron donor |
US20090176194A1 (en) * | 2008-01-07 | 2009-07-09 | Kerr Corporation | Method of cementing prosthetic devices and cementation kit |
EP2133063A1 (en) * | 2008-06-10 | 2009-12-16 | 3M Innovative Properties Company | Initiator system with biphenylene derivates, method of production and use thereof |
CN102076310B (en) * | 2008-07-25 | 2013-01-16 | 株式会社德山齿科 | Dental adhesive composition |
US20110171609A1 (en) * | 2008-09-04 | 2011-07-14 | Jie Yang | Dental Composition Comprising Biphenyl Di(meth)acrylate Monomer |
WO2010039395A2 (en) * | 2008-09-30 | 2010-04-08 | 3M Innovative Properties Company | Orthodontic composition with heat modified minerals |
EP2344107B1 (en) | 2008-10-15 | 2017-02-08 | 3M Innovative Properties Company | Dental compositions with fluorescent pigment |
EP2376573B1 (en) * | 2008-10-22 | 2019-12-18 | 3M Innovative Properties Company | Dental composition comprising biphenyl di(meth)acrylate monomer comprising urethane moieties |
WO2010068359A1 (en) | 2008-12-11 | 2010-06-17 | 3M Innovative Properties Company | Surface-treated calcium phosphate particles suitable for oral care and dental compositions |
EP2228049B1 (en) | 2009-03-09 | 2016-11-09 | Dentsply DeTrey GmbH | Dental composition |
WO2010106903A1 (en) * | 2009-03-18 | 2010-09-23 | クラレメディカル株式会社 | Redox-curing type composition |
DE102009016025B4 (en) | 2009-04-02 | 2014-12-11 | Voco Gmbh | Plastic modified glass ionomer cement, its use and process for its preparation |
EP2470497A2 (en) | 2009-08-28 | 2012-07-04 | 3M Innovative Properties Company | Polymerizable ionic liquid comprising multifunctional cation and antistatic coatings |
US8816029B2 (en) | 2009-08-28 | 2014-08-26 | 3M Innovative Properties Company | Compositions and articles comprising polymerizable ionic liquid mixture, and methods of curing |
EP2316407B1 (en) | 2009-10-30 | 2021-04-28 | Dentsply DeTrey GmbH | Dental composition |
EP2329807A1 (en) | 2009-12-07 | 2011-06-08 | Dentsply DeTrey GmbH | Dental composition |
MX2012006912A (en) * | 2009-12-15 | 2012-07-10 | Ca Nat Research Council | Cellulose nanocrystals from renewable biomass. |
EP2335668A1 (en) | 2009-12-15 | 2011-06-22 | Dentsply DeTrey GmbH | Dental composition |
RU2012131166A (en) | 2009-12-22 | 2014-01-27 | 3М Инновейтив Пропертиз Компани | CURABLE DENTAL COMPOSITIONS AND ARTICLES CONTAINING POLYMERIZABLE IONIC LIQUIDS |
WO2011104704A2 (en) * | 2010-02-24 | 2011-09-01 | Corona Dent. Ltd. | Long lasting dental restorations and methods for preparation thereof |
US9237990B2 (en) | 2010-03-31 | 2016-01-19 | 3M Innovative Properties Company | Polymerizable isocyanurate monomers and dental compositions |
JP5818879B2 (en) | 2010-05-18 | 2015-11-18 | スリーエム イノベイティブ プロパティズ カンパニー | Polymerizable ionic liquids containing aromatic carboxylate anions |
WO2011149631A2 (en) | 2010-05-25 | 2011-12-01 | 3M Innovative Properties Company | Method of surface treating inorganic oxide particles, hardenable dental compositions, surface treated particles, and surface treatment compounds |
WO2011152571A1 (en) * | 2010-05-31 | 2011-12-08 | (주) 베리콤 | Dental antibacterial cement composition |
US9044292B2 (en) | 2010-08-11 | 2015-06-02 | 3M Innovative Properties Company | Dental articles including a ceramic and microparticle coating and method of making the same |
EP2603159A1 (en) | 2010-08-11 | 2013-06-19 | 3M Innovative Properties Company | Aesthetic and abrasion resistant coated dental articles and methods of making the same |
US20130130203A1 (en) | 2010-08-11 | 2013-05-23 | 3M Innovative Properties Company | Polymer coated dental articles and method of making the same |
EP2603161A1 (en) | 2010-08-11 | 2013-06-19 | 3M Innovative Properties Company | Coated dental crows and method of making the same |
EP2444053B1 (en) | 2010-10-19 | 2020-05-06 | Dentsply DeTrey GmbH | Dental cement composition |
EP2444054A1 (en) | 2010-10-19 | 2012-04-25 | Dentsply DeTrey GmbH | Dental composition |
EP2444052A1 (en) | 2010-10-19 | 2012-04-25 | Dentsply DeTrey GmbH | Dental composition |
US9522099B2 (en) | 2010-11-04 | 2016-12-20 | Kerr Corporation | Dental compositions having special functionality and a tri-barrel packaging and delivery system therefor |
US9399004B2 (en) * | 2010-11-04 | 2016-07-26 | Kerr Corporation | Dental composition having a redox indicator and method of using same |
BR112013016445B8 (en) | 2010-12-30 | 2021-01-05 | 3M Innovative Properties Co | method for manufacturing a dental set |
JP6077463B2 (en) | 2011-02-15 | 2017-02-08 | スリーエム イノベイティブ プロパティズ カンパニー | Dental composition containing an ethylenically unsaturated addition cleavage agent |
WO2012112321A2 (en) | 2011-02-15 | 2012-08-23 | 3M Innovative Properties Company | Dental compositions comprising mixture of isocyanurate monomer and tricyclodecane monomer |
EP2497454A1 (en) | 2011-03-10 | 2012-09-12 | Dentsply DeTrey GmbH | Dental composition |
US20140017637A1 (en) | 2011-03-24 | 2014-01-16 | 3M Iinnovative Properties Company | Dental adhesive comprising a coated polymeric component |
EP2726049B1 (en) | 2011-06-29 | 2022-08-17 | 3M Innovative Properties Company | Dental compositions comprising a fatty mono(meth)acrylate |
EP2747737B1 (en) | 2011-08-23 | 2019-09-25 | 3M Innovative Properties Company | Dental compositions comprising addition-fragmentation agents |
EP2662067A1 (en) | 2012-05-11 | 2013-11-13 | Dentsply DeTrey GmbH | Dental composition |
EP2705827B1 (en) | 2012-09-11 | 2017-12-27 | DENTSPLY DETREY GmbH | Dental composition |
JP5901487B2 (en) | 2012-09-28 | 2016-04-13 | 株式会社ジーシー | Polymerizable composition |
EP2727576A1 (en) | 2012-11-05 | 2014-05-07 | DENTSPLY DETREY GmbH | Dental composition |
JP6351608B2 (en) | 2012-11-12 | 2018-07-04 | スリーエム イノベイティブ プロパティズ カンパニー | Dental composition comprising an additional cleavage agent |
CN104870484B (en) | 2012-12-17 | 2016-11-23 | 3M创新有限公司 | Addition-fracture oligomer |
EP2759289A1 (en) | 2013-01-24 | 2014-07-30 | DENTSPLY DETREY GmbH | Polymerizable dental composition |
US9408781B2 (en) | 2013-02-11 | 2016-08-09 | Kerr Corporation | Dental resin modified glass-ionomer composition |
CN105051007B (en) | 2013-03-20 | 2020-03-13 | 3M创新有限公司 | High refractive index addition-fragmentation agents |
US9675529B2 (en) | 2013-04-15 | 2017-06-13 | 3M Innovative Properties Company | Dental composition containing high refractive index monomers |
EP3046962B1 (en) | 2013-09-20 | 2018-05-23 | 3M Innovative Properties Company | Trithiocarbonate-containing addition-fragmentation agents |
US9758478B2 (en) | 2013-10-16 | 2017-09-12 | 3M Innovative Properties Company | Allyl disulfide-containing addition-fragmentation oligomers |
JP6247550B2 (en) * | 2014-01-27 | 2017-12-13 | 株式会社トクヤマデンタル | Dental adhesive |
JP6247549B2 (en) * | 2014-01-27 | 2017-12-13 | 株式会社トクヤマデンタル | Dental pretreatment material and dental filling and repair kit |
US9730864B2 (en) | 2014-02-18 | 2017-08-15 | 3M Innovative Properties Company | Addition-fragmentation oligomers having high refractive index groups |
US9289360B2 (en) | 2014-04-17 | 2016-03-22 | Dentsply International Inc. | Dental composition |
EP2949311B1 (en) * | 2014-05-30 | 2019-10-16 | Shofu Inc. | Dental composition containing ion sustained-release glass |
US10932994B2 (en) | 2014-07-10 | 2021-03-02 | 3M Innovative Properties Company | Two-component self-adhesive dental composition, process of production and use thereof |
US10449692B2 (en) | 2014-12-08 | 2019-10-22 | Tethon Corporation | Three-dimensional (3D) printing |
CN107406723B (en) | 2015-02-20 | 2021-05-07 | 3M创新有限公司 | Addition-fragmentation oligomers |
EP3106146A1 (en) | 2015-06-15 | 2016-12-21 | Dentsply DeTrey GmbH | Aqueous dental glass ionomer composition |
US10470981B2 (en) * | 2015-08-28 | 2019-11-12 | Gc Corporation | Dental cement |
EP3141567B1 (en) | 2015-09-09 | 2019-08-28 | DENTSPLY DETREY GmbH | Polymerizable polyacidic polymer |
WO2017079189A1 (en) | 2015-11-06 | 2017-05-11 | 3M Innovative Properties Company | Redox polymerizable dental composition with photolabile transition metal complexes |
EP3370680B1 (en) | 2015-11-06 | 2020-11-25 | 3M Innovative Properties Company | Redox polymerizable composition with photolabile transition metal complexes |
EP3383924B1 (en) | 2015-12-03 | 2021-04-14 | 3M Innovative Properties Company | Redox polymerizable composition with photolabile reducing agents |
CN108366911A (en) | 2015-12-08 | 2018-08-03 | 3M创新有限公司 | Two component autoadhesion dental compositions, the initiator system and their purposes of stable storing |
EP3231411B1 (en) | 2016-04-15 | 2021-11-10 | DENTSPLY DETREY GmbH | Aqueous dental glass ionomer composition |
EP3231412A3 (en) | 2016-04-15 | 2017-10-25 | DENTSPLY DETREY GmbH | Aqueous dental glass ionomer composition |
RU2623863C1 (en) * | 2016-04-26 | 2017-06-29 | Сергей Владимирович Сирак | Dental material for insulating gasket for advanced caries and acute focal pulpitis |
EP3246002A1 (en) | 2016-05-20 | 2017-11-22 | DENTSPLY DETREY GmbH | Dental composition |
JP6845496B2 (en) * | 2016-06-20 | 2021-03-17 | 協立化学産業株式会社 | Microcapsules, methods for producing microcapsules and curable compositions |
EP3263089A1 (en) | 2016-06-30 | 2018-01-03 | Dentsply DeTrey GmbH | Dental composition comprising a dental filler containing a structural filler and silanated glass flakes |
EP3300714A1 (en) * | 2016-09-30 | 2018-04-04 | DENTSPLY DETREY GmbH | Dental composition |
WO2018075275A1 (en) | 2016-10-20 | 2018-04-26 | 3M Innovative Properties Company | Photoinitiators with protected carbonyl group |
CN110035734A (en) | 2016-12-01 | 2019-07-19 | 3M创新有限公司 | The alkaline core material being encapsulated in inorganic shell suitable for biological carrier materials |
WO2018102197A1 (en) | 2016-12-02 | 2018-06-07 | 3M Innovative Properties Company | Dual cure monomers |
EP3336092A1 (en) | 2016-12-14 | 2018-06-20 | DENTSPLY DETREY GmbH | Dental composition |
EP3335689A1 (en) | 2016-12-14 | 2018-06-20 | DENTSPLY DETREY GmbH | Dental composition |
EP3338757A1 (en) | 2016-12-20 | 2018-06-27 | Dentsply DeTrey GmbH | Direct dental filling composition |
EP3338756B1 (en) | 2016-12-21 | 2020-02-26 | VOCO GmbH | Storage-stable resin-modified glass ionomer cement |
EP3339335A1 (en) | 2016-12-22 | 2018-06-27 | Dentsply DeTrey GmbH | Process for preparing a dental resin-modified glass ionomer composition |
EP3449895A1 (en) | 2017-08-30 | 2019-03-06 | Dentsply DeTrey GmbH | Photoinitiator modified polyacidic polymer |
WO2019043114A1 (en) | 2017-08-30 | 2019-03-07 | Dentsply Detrey Gmbh | Photoinitiator modified polyacidic polymer |
EP3449894A1 (en) | 2017-08-31 | 2019-03-06 | Dentsply DeTrey GmbH | Dental composition comprising a particulate carrier supporting a coinitiator |
WO2019123260A2 (en) | 2017-12-19 | 2019-06-27 | 3M Innovative Properties Company | Multi-part composition having staged viscosity prior to hardening |
JP6865898B2 (en) | 2017-12-21 | 2021-04-28 | スリーエム イノベイティブ プロパティズ カンパニー | Dental inorganic filler with silane treated surface |
CA3087255A1 (en) | 2018-01-03 | 2019-07-11 | Dentsply Sirona Inc. | Dental composition |
WO2019155334A1 (en) | 2018-02-06 | 2019-08-15 | 3M Innovative Properties Company | Microcapsule with a porous or hollow core and ph-sensitive shell use thereof |
EP3530259A1 (en) | 2018-02-22 | 2019-08-28 | Dentsply DeTrey GmbH | Dental composition |
EP3536303A1 (en) | 2018-03-07 | 2019-09-11 | Dentsply DeTrey GmbH | Dental composition |
EP3542779B1 (en) | 2018-03-21 | 2021-12-01 | Dentsply DeTrey GmbH | Dental composition |
CN112566585B (en) | 2018-06-06 | 2022-07-12 | 3M创新有限公司 | Hardenable dental compositions comprising alkaline core material encapsulated in an inorganic shell and dispensing devices therefor |
US20220033345A1 (en) | 2018-10-09 | 2022-02-03 | 3M Innovative Properties Company | Addition-fragmentation agent with pendent amine groups |
EP3659546B1 (en) | 2018-11-27 | 2022-10-19 | Dentsply DeTrey GmbH | Additive manufacturing process |
KR20200115256A (en) | 2019-03-26 | 2020-10-07 | 소후 인코포레이티드 | Powder-liquid type resin-reinforced dental glass ionomer cement composition |
AU2020259278A1 (en) | 2019-04-15 | 2021-10-07 | Dentsply Sirona Inc. | Dental composition |
CN113905812A (en) | 2019-06-04 | 2022-01-07 | 3M创新有限公司 | Microcapsules having a porous or hollow core and a shell comprising a component that releases a gas upon contact with an acid |
EP3834805A1 (en) | 2019-12-12 | 2021-06-16 | DENTSPLY SIRONA Inc. | Dental resin modified glass-ionomer composition and kit comprising said composition |
CN116507309A (en) | 2020-12-04 | 2023-07-28 | 3M创新有限公司 | Dental pH sensitive microcapsules |
WO2023228049A1 (en) | 2022-05-26 | 2023-11-30 | 3M Innovative Properties Company | Dental compositions and methods of making and using same |
WO2024038364A1 (en) | 2022-08-16 | 2024-02-22 | Solventum Intellectual Properties Company | Dental compositions and methods of making and using same |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1139430A (en) * | 1966-12-30 | 1969-01-08 | Nat Res Dev | Improvements relating to surgical cements |
US3814717A (en) * | 1970-12-04 | 1974-06-04 | Dental Materials Section Labor | Poly(carboxylic acid)-fluoroalumino-silicate glass surgical cement |
US4209434A (en) * | 1972-04-18 | 1980-06-24 | National Research Development Corporation | Dental cement containing poly(carboxylic acid), chelating agent and glass cement powder |
GB1532954A (en) * | 1974-10-24 | 1978-11-22 | Nat Res Dev | Poly-(carboxylate)cements |
NL7604906A (en) * | 1975-05-13 | 1976-11-16 | Smith & Nephew Res | HARDENABLE COMPOSITIONS. |
DK535977A (en) * | 1976-12-03 | 1978-06-04 | Smith & Nephew Res | F MEDICAL BINDING AND METHOD OF MANUFACTURE THEREOF |
US4539382A (en) * | 1981-07-29 | 1985-09-03 | Kuraray Co., Ltd. | Adhesive composition |
US4503161A (en) * | 1984-03-23 | 1985-03-05 | Minnesota Mining And Manufacturing Company | Latent Lewis acid catalyst encapsulated within polymerized cycloaliphatic epoxide and polyhydric alcohol |
DE3536076A1 (en) * | 1985-10-09 | 1987-04-09 | Muehlbauer Ernst Kg | POLYMERIZABLE CEMENT MIXTURES |
IE852919L (en) * | 1985-11-21 | 1987-05-21 | Loctite Ireland Ltd | Activation of adhesive compositions |
JPH0653647B2 (en) * | 1986-04-18 | 1994-07-20 | 而至歯科工業株式会社 | Dental restoration composition |
EP0312525A1 (en) * | 1987-02-04 | 1989-04-26 | Dental Composite Ltd. | Radiopaque glass ionomer cement liner for dental cavities |
AU618772B2 (en) * | 1987-12-30 | 1992-01-09 | Minnesota Mining And Manufacturing Company | Photocurable ionomer cement systems |
AU2773789A (en) * | 1988-01-15 | 1989-07-20 | Kerr Manufacturing Company | Dual curing glass ionomer dental cement |
JPH0627047B2 (en) * | 1988-12-16 | 1994-04-13 | 而至歯科工業株式会社 | Dental glass ionomer cement composition |
CA2011438C (en) * | 1989-04-06 | 1996-02-13 | Robert L. Ibsen | Light-curable ionomer dental cement |
-
1991
- 1991-05-31 US US07/708,988 patent/US5154762A/en not_active Expired - Lifetime
-
1992
- 1992-05-19 CA CA002110259A patent/CA2110259C/en not_active Expired - Fee Related
- 1992-05-19 AU AU20092/92A patent/AU2009292A/en not_active Abandoned
- 1992-05-19 DE DE69214287T patent/DE69214287T2/en not_active Expired - Lifetime
- 1992-05-19 ES ES92912026T patent/ES2092118T3/en not_active Expired - Lifetime
- 1992-05-19 WO PCT/US1992/004164 patent/WO1992021314A1/en active IP Right Grant
- 1992-05-19 DK DK92912026.9T patent/DK0588878T3/en active
- 1992-05-19 BR BR9206071A patent/BR9206071A/en not_active IP Right Cessation
- 1992-05-19 JP JP50043593A patent/JP3288698B2/en not_active Expired - Fee Related
- 1992-05-19 EP EP92912026A patent/EP0588878B2/en not_active Expired - Lifetime
- 1992-05-19 KR KR1019930703633A patent/KR100245578B1/en not_active IP Right Cessation
- 1992-05-25 ZA ZA923812A patent/ZA923812B/en unknown
- 1992-05-28 MX MX9202548A patent/MX9202548A/en not_active IP Right Cessation
-
1993
- 1993-11-26 NO NO934303A patent/NO303524B1/en not_active IP Right Cessation
-
1996
- 1996-11-18 AU AU71870/96A patent/AU701111B2/en not_active Ceased
-
1998
- 1998-06-26 HK HK98107043A patent/HK1007687A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU7187096A (en) | 1997-02-06 |
EP0588878B2 (en) | 2008-07-02 |
MX9202548A (en) | 1992-11-01 |
BR9206071A (en) | 1994-12-27 |
AU701111B2 (en) | 1999-01-21 |
EP0588878B1 (en) | 1996-10-02 |
ZA923812B (en) | 1993-01-27 |
WO1992021314A1 (en) | 1992-12-10 |
NO934303L (en) | 1994-01-31 |
AU2009292A (en) | 1993-01-08 |
CA2110259A1 (en) | 1992-12-10 |
HK1007687A1 (en) | 1999-04-23 |
DK0588878T3 (en) | 1997-03-17 |
KR100245578B1 (en) | 2000-03-02 |
US5154762A (en) | 1992-10-13 |
NO303524B1 (en) | 1998-07-27 |
NO934303D0 (en) | 1993-11-26 |
DE69214287D1 (en) | 1996-11-07 |
EP0588878A1 (en) | 1994-03-30 |
JPH08500080A (en) | 1996-01-09 |
DE69214287T2 (en) | 1997-04-24 |
JP3288698B2 (en) | 2002-06-04 |
ES2092118T3 (en) | 1996-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2110259C (en) | Universal water-based medical and dental cement | |
US5227413A (en) | Cements from β-dicarbonyl polymers | |
AU2002305351B2 (en) | Glass ionomer cement | |
US6818682B2 (en) | Multi-part dental compositions and kits | |
CA1337619C (en) | Photocurable ionomer cement systems | |
US5814682A (en) | Method of luting a provisional prosthetic device using a glass ionomer cement system and kit therefor | |
AU2002305351A1 (en) | Glass ionomer cement | |
EP0906076A1 (en) | Glass ionomer cement | |
JP2004517107A (en) | Dental materials | |
AU720490B2 (en) | Improvements in or relating to polymerisable cement compositions | |
CA2182875A1 (en) | Paste:paste glass ionomer cement system and methods | |
AU3326193A (en) | Water-based amalgam adhesive | |
EP0836468B1 (en) | Method of luting a provisional prosthetic device using a glass ionomer cement system and kit therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |